Gene | Description | Sequences | Sequence assembly | Predicted SNPs having score >= 0.99 |
A1BG | Alpha-1-B glycoprotein | T80683, W25099, AA484435, AI022193 | AI022193 | |
A2M | Alpha-2-macroglobulin | M11313 | M11313 | 1 |
AAA | Achalasia-addisonianism-alacrimia syndrome (Allgrove syndrome) | |||
AABT | Beta-amino acids, renal transport of | |||
AACT | Alpha-1-antichymotrypsin | J05176, K01500 | X68733 | Location 1 (1) Location 2 (1) |
AARS | Alanyl-tRNA synthetase | D32050 | D32050 | |
ABAT | 4-aminobutyrate aminotransferase | L32961 | ||
ABC7 | ATP-binding cassette 7 | AA626765, AB005289, AF038950 | AB005289 | |
ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) | U15197, U22302, AC000397 | ||
ACADL | Acyl-Coenzyme A dehydrogenase, long chain | M74096 | M74096 | |
ACADM | Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain | M16827 | ||
ACADS | Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain | M26393, Z80347 | Z80345 | 1 |
ACAT2 | Acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase) | S70154 | X52882 S70154 | Location 1 (1) Location 2 (1) Location 3 (3) Location 4 (1) |
ACHE | Acetylcholinesterase (YT blood group) | M55040 | M55040 | 2 |
ACLS | Acrocallosal syndrome | |||
ACO1 | Aconitase 1, soluble | |||
ACO2 | Aconitase 2, mitochondrial | U80040, U87926, U87927, U87928, U87929, U87930, U87931, U87932, U87933, U87934, U87935, U87936, U87937, U87938, U87939 | U80040 | |
ACP1 | Acid phosphatase 1, soluble | U25847, U25849 | U25849 | 4 |
ACP5 | Acid phosphatase 5, tartrate resistant | J04430, X14618 | J04430 | |
ACTC | Actin, alpha, cardiac muscle | J00073 | J00073 | |
ACTG2 | Actin, gamma 2, smooth muscle, enteric | D00648, D00649, D00650, D00651, D00652, D00653, D00654, X16940 | X16940 | |
ACTN2 | Actinin, alpha 2 | M86406 | M86406 | |
ACUG | Arthrocutaneouveal granulomatosis (Blau syndrome) | |||
ACY1 | Aminoacylase 1 | L07548 | L07548 | |
ADA | Adenosine deaminase | K02567, X02994 | X02994 | |
ADAM10 | A disintegrin and metalloprotease domain 10 | AF009615 | AF009615 | |
ADAM8 | A disintegrin and metalloprotease domain 8 | D26579 | D26579 | |
ADCYAP1 | Adenylate cyclase activating polypeptide 1 (pituitary) | S83513, X60435 | ||
ADD1 | Adducin 1 (alpha) | L07261, Z68280 | L11669 Z68280 | |
ADH1 | Alcohol dehydrogenase 1 (class I), alpha polypeptide | M12271, M12963 | ||
ADH2 | Alcohol dehydrogenase 2 (class I), beta polypeptide | D00137, M21692, M24317, X03350 | X03350 | |
ADH3 | Alcohol dehydrogenase 3 (class I), gamma polypeptide | M12272, X04299, X04350 | M12272 | |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | M15943 | X56411 | 1 |
ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | M29872, M30471 | ||
ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | M29872, M30471 | ||
ADK | Adenosine kinase | U50196 | U50196 | |
ADORA1 | Adenosine A1 receptor | L22214, X68485 | L22214 | |
ADORA2A | Adenosine A2a receptor | M97370, S46950, U40771, X68486 | X68486 | |
ADORA2A | Adenosine A2a receptor | M97370, S46950, U40771, X68486 | X68486 | |
ADPRT | ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase) | J03473, M29786, M32721 | J03473 | 1 |
ADRA2A | Adrenergic, alpha-2A-, receptor | M18415, M23533 | ||
ADRA2B | Adrenergic, alpha-2B-, receptor | M34041 | ||
ADRA2C | Adrenergic, alpha-2C-, receptor | D13538, X72924 | J03853 | |
ADRB1 | Adrenergic, beta-1-, receptor | J03019 | ||
ADRB2 | Adrenergic, beta-2-, receptor, surface | J02960, M15169, X04827, AF022953 | M15169 | |
ADRB3 | Adrenergic, beta-3-, receptor | M29932, X70811, X72861 | ||
ADSS | Adenylosuccinate synthase | X66503 | X66503 | |
AFP | Alpha-fetoprotein | J00077, M16110 | V01514 | 1 |
AGA | Aspartylglucosaminidase | M64076, X55330, X55762 | X55330 | 3 |
AGMX2 | Agammaglobulinemia, X-linked 2 (with growth hormone deficiency) | |||
AGT | Angiotensinogen | K02215 | K02215 | 7 |
AGTR1 | Angiotensin receptor 1 | M87290 | S77410 | |
AGTR2 | Angiotensin receptor 2 | L34579, U16957 | ||
AGXT | Alanine-glyoxylate aminotransferase (oxalosis I; hyperoxaluria I; glycolicaciduria; serine-pyruvate aminotransferase) | D13368, M61763, X53414, X56092 | X53414 | |
AHCY | S-adenosylhomocysteine hydrolase | M61831 | M61832 M61831 | 4 |
AHR | Aryl hydrocarbon receptor | D16354, L19872 | L19872 | |
AHSG | Alpha-2-HS-glycoprotein | D67013, M16961 | M16961 | 1 |
AIH2 | Amelogenesis imperfecta 2, hypocalcification (autosomal dominant) | |||
AIRE | Autoimmune regulator (automimmune polyendocrinopathy candidiasis ectodermal dystrophy) | Z97990, AB006683, AB006684, AB006685 | ||
AK1 | Adenylate kinase 1 | J04809 | J04809 | 1 |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | M63167 | M63167 | |
ALAD | Aminolevulinate, delta-, dehydratase | M13928 | ||
ALAS2 | Aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia) | X56352 | ||
ALB | Albumin | M12523 | ||
ALD | Adrenoleukodystrophy/adrenomyeloneuropathy | Z21876 | ||
ALDH1 | Aldehyde dehydrogenase 1, soluble | K03000, AF003341 | K03000 | 2 |
ALDH2 | Aldehyde dehydrogenase 2, mitochondrial | M20456 | ||
ALDH6 | Aldehyde dehydrogenase 6 | U07919 | U07919 | 2 |
ALDH9 | Aldehyde dehydrogenase 9 (gamma-aminobutyraldehyde dehydrogenase, E3 isozyme) | U34252 | U34252 | 3 |
ALDOA | Aldolase A, fructose-bisphosphate | M11560, M21190, X05236, X12447 | M11560 | Location 1 (1) Location 2 (1) |
ALDOB | Aldolase B, fructose-bisphosphate | K01177, X00270, X01098, X02747 | X02747 | Location 1 (4) Location 2 (1) |
ALOX12 | Arachidonate 12-lipoxygenase | M35418, M58704, M62982 | ||
ALOX5 | Arachidonate 5-lipoxygenase | J03571, J03600 | J03600 | 1 |
ALPL | Alkaline phosphatase, liver/bone/kidney | D87874, D87875, D87876, D87877, D87878, D87879, D87880, D87881, D87882, D87883, D87884, D87885, D87886, D87887, D87888, D87889, M24439 | AB011406 | |
ALPP | Alkaline phosphatase, placental (Regan isozyme) | |||
ALPPL2 | Alkaline phosphatase, placental-like 2 | |||
AMBP | Alpha-1-microglobulin/bikunin precursor | M11562, X04225, X04494, X54816, X54817, X54818 | M88249 | |
AMCN | Arthrogryposis multiplex congenita, neurogenic | |||
AMELX | Amelogenin (X chromosome, amelogenesis imperfecta 1) | M86932 | ||
AMH | Anti-Mullerian hormone | K03474 | AC005263 | |
AMPH | Amphiphysin (Stiff-Mann syndrome with breast cancer 128kD autoantigen) | X81438 | X81438 | 1 |
AMPHL | Amphiphysin-like | U68485, AF068918 | U84004 | |
AMY1A | Amylase, alpha 1A; salivary | K02214, M18715 | ||
AMY2A | Amylase, alpha 2A; pancreatic | M28443 | ||
ANK1 | Ankyrin 1, erythrocytic | M28880, U50133, AF005213 | X16609 | |
ANPEP | Alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150) | M22324 | M22324 | 2 |
ANX11 | Annexin XI (56kD autoantigen) | L19605 | L19605 | |
ANX3 | Annexin III (lipocortin III, 1,2-cyclic-inositol-phosphate phosphodiesterase, placental anticoagulant protein III, calcimedin 35-alpha) | M20560, M63310 | M20560 | 2 |
ANX4 | Annexin IV (placental anticoagulant protein II) | D78152, M19383, M82809 | M82809 | 1 |
ANX5 | Annexin V (endonexin II) | D00172, J03745, M18366, M19384, M21731, U05770, X12454 | U05770 | 1 |
ANX8 | Annexin VIII | M81844, X16662 | X16662 | 3 |
APAF1 | Apoptotic protease activating factor | AF013263 | AF013263 | 1 |
APBA2 | Amyloid beta (A4) precursor protein-binding, family A, member 2 (X11-like) | AB014719, AF047348 | AF047348 | |
APBB1 | Amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | L77864 | L77864 | |
APC | Adenomatosis polyposis coli | M73548, M74088 | M73548 | 1 |
APCS | Amyloid P component, serum | M10944, X04608 | D00097 | |
APEH | N-acylaminoacyl-peptide hydrolase | J03068 | J03068 | |
API1 | Apoptosis inhibitor 1 | L49432, U45878 | AF070674 | |
API2 | Apoptosis inhibitor 2 | L49431, U45879 | U37547 | |
API3 | Apoptosis inhibitor 3 | U45880 | ||
API4 | Apoptosis inhibitor 4 (survivin) | U75285 | U75285 | |
APOA1 | Apolipoprotein A-I | M27875, X02162 | X02162 | 2 |
APOA2 | Apolipoprotein A-II | M29882, X00955 | X04898 | 1 |
APOA4 | Apolipoprotein A-IV | J02758, M13654, M14566, X13629 | ||
APOB | Apolipoprotein B (including Ag(x) antigen) | J02610, M10374, M14162, X04506 | X04506 | |
APOC2 | Apolipoprotein C-II | J02698, M29844, X00568 | X05151 | |
APOC3 | Apolipoprotein C-III | M28613, M28614, V01513, X00567, X01388, X01392 | X01388 | 1 |
APOD | Apolipoprotein D | J02611, M16648, M16649, M16695, M16696 | J02611 | 3 |
APOE | Apolipoprotein E | K00396, M12529 | M12529 | 1 |
APOH | Apolipoprotein H (beta-2-glycoprotein I) | S80305, X53595, X58100 | M62839 | 3 |
APP | Amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) | M24546, M33112, M34862, M34863, M34864, M34865, M34866, M34867, M34868, M34869, M34870, M34871, M34872, M34873, M34874, M34875, M34876, M34877, M34878, M34879 | D87675 | |
APRT | Adenine phosphoribosyltransferase | M16446, Y00486 | Y00486 | Location 1 (1) Location 2 (1) |
AQP1 | Aquaporin 1 (channel-forming integral protein, 28kD) | U41517, U41518 | U41518 | 1 |
AQP2 | Aquaporin 2 (collecting duct) | S73196, S73197, Z29491 | ||
AR | Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease) | M20132, M20260, M21748, M23263, M27430, M34233 | M23263 | |
AREG | Amphiregulin (schwannoma-derived growth factor) | M30698, M30699, M30700, M30701, M30702, M30703, M30704 | M30704 | |
ARHE | Ras homolog gene family, member E | S82240 | S82240 | |
ARHGAP1 | Rho GTPase activating protein 1 | Z23024 | U02570 | 1 |
ARHGAP5 | Rho GTPase activating protein 5 | U17032 | U17032 | |
ARNT | Aryl hydrocarbon receptor nuclear translocator | M69238 | ||
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | D89722 | AF044288 | |
ARSA | Arylsulfatase A | U62317, X52150, X52151 | X52151 U62317 | Location 1 (1) Location 2 (1) |
ART1 | ADP-ribosyltransferase 1 | S74683 | ||
ARVD2 | Arrhythmogenic right ventricular dysplasia 2 | |||
ASL | Argininosuccinate lyase | J03058, M14218 | M14218 | |
ASNS | Asparagine synthetase | L35946, M16763, M27396 | M27396 | |
ASPH | Aspartate beta-hydroxylase | U03109 | U03109 | |
AT3 | Antithrombin III | D29832, L00190, X68793 | L00190 | |
ATCAY | Ataxia, cerebellar, Cayman type | |||
ATM | Ataxia telangiectasia mutated (includes complementation groups A, C and D) | U33841, U82828 | D83243 U82828 | 1 |
ATOX1 | ATX1 (antioxidant protein 1, yeast) homolog 1 | U70660 | U70660 | 1 |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | U16798 | D00099 | Location 1 (1) Location 2 (1) |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | L00620, L20977, M97260, U15688 | ||
ATP4B | ATPase, H+/K+ exchanging, beta polypeptide | M75110 | ||
ATP7B | ATPase, Cu++ transporting, beta polypeptide (Wilson disease) | L25591, U03464, U11700 | U11700 | |
ATR | Ataxia telangiectasia and Rad3 related | U76308 | U49844 | |
ATRN | Attractin (with dipeptidylpeptidase IV activity) | |||
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | U09820 | U72936 | |
ATSV | Axonal transport of synaptic vesicles | X90840 | X90840 | |
AUH | AU RNA-binding protein/enoyl-Coenzyme A hydratase | X79888 | X79888 | |
AVP | Arginine vasopressin (neurophysin II, antidiuretic hormone, diabetes insipidus, neurohypophyseal) | M11166, M25647 | ||
AVPR1A | Arginine vasopressin receptor 1A | L25615 | L25615 | |
AVPR2 | Arginine vasopressin receptor 2 (nephrogenic diabetes insipidus) | L22206, Z11687 | L76191 U52112 | |
AXL | AXL receptor tyrosine kinase | M76125, S65125, X57019 | M76125 | 2 |
AZGP1 | Alpha-2-glycoprotein 1, zinc | D90427, M76707, X59766 | X59766 | 1 |
AZU1 | Azurocidin 1 (cationic antimicrobial protein 37) | M96326, X58794 | ||
B120 | Brain protein 120 | AB001895 | AB001895 | |
B2M | Beta-2-microglobulin | M17987, AB021288 | ||
BAG1 | BCL2-associated athanogene | AF022224 | Z35491 | |
BAK1 | BCL2-antagonist/killer 1 | U16811, X84213 | U16811 | |
BAX | BCL2-associated X protein | L22474 | ||
BCHE | Butyrylcholinesterase | M16541, M32391 | M16541 | 1 |
BCKDHA | Branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease) | J04474, M22221 | Z14093 | 1 |
BCL1 | B-cell CLL/lymphoma 1 | Z23022 | ||
BCL2 | B-cell CLL/lymphoma 2 | M13994, M13995, M14745 | M14745 | |
BCL2A1 | BCL2-related protein A1 | U27467, U29680 | U29680 | 1 |
BCL2L1 | BCL2-like 1 | Z23115, Z23116 | Z23115 | 1 |
BCL2L2 | BCL2-like 2 | U59747 | D87461 | |
BCL7 | B-cell CLL/lymphoma 7 | X89984 | ||
BCPM | Benign chronic pemphigus (Hailey-Hailey disease) | |||
BCPR | Breast cancer-related regulator of TP53 | |||
BCR | Breakpoint cluster region | U07000 | Y00661 | 1 |
BDKRB1 | Bradykinin receptor B1 | U12512, U22346 | ||
BDKRB2 | Bradykinin receptor B2 | M88714, X86162, X86172, X86173 | X86163 | 1 |
BENE | BENE protein | U17077 | U17077 | 1 |
BF | B-factor, properdin | L15702 | L15702 | 2 |
BGLAP | Bone gamma-carboxyglutamate (gla) protein (osteocalcin) | X04143, X51699, X53698 | X51699 | |
BGP | Biliary glycoprotein | D90311, D90312, D90313, J03858, S71326 | X16354 | 1 |
BHR1 | Bronchial hyperresponsiveness-1 (bronchial asthma) | |||
BID | BH3 interacting domain death agonist | AF042083 | AF042083 | 1 |
BLK | B lymphoid tyrosine kinase | S76617, Z33998 | S76617 | 1 |
BLM | Bloom syndrome | U39817 | U39817 | |
BLMH | Bleomycin hydrolase | X92106 | X92106 | |
BMI1 | Murine leukemia viral (bmi-1) oncogene homolog | L13689 | L13689 | |
BN51T | BN51 (BHK21) temperature sensitivity complementing | M17754 | M17754 | 2 |
BPAG1 | Bullous pemphigoid antigen 1 (230/240kD) | L08972, L11690, M22942, M69225 | M69225 | |
BPI | Bactericidal/permeability-increasing protein | J04739 | J04739 | |
BRAF | V-raf murine sarcoma viral oncogene homolog B1 | M95712, M95720, X54072 | M95712 | |
BRAK | CXC chemokine in breast and kidney | AF073957 | ||
BRCA1 | Breast cancer 1, early onset | U14680, AF005068 | L78833 | 1 |
BRCA2 | Breast cancer 2, early onset | U43746 | X95152 | 1 |
BSEP | Bile salt export pump (ABC member 16, MDR/TAP subfamily) | AF091582 | ||
BST1 | Bone marrow stromal cell antigen 1 | D21878 | D21878 | |
BTD | Biotinidase | U03274 | U03274 | |
BTK | Bruton agammaglobulinemia tyrosine kinase | U10087, X58957 | U78027 U01923 | 3 |
BUB1 | Budding uninhibited by benzimidazoles 1 (yeast homolog) | AF046078 | AF053305 | |
C1NH | Complement component 1 inhibitor (angioedema, hereditary) | M13656, M13690, X54486 | X54486 | |
C1QA | Complement component 1, q subcomponent, alpha polypeptide | |||
C1QB | Complement component 1, q subcomponent, beta polypeptide | K03430, X03084 | X03084 | 2 |
C1QBP | Complement component 1, q subcomponent binding protein | X75913 | M69039 | 2 |
C1QG | Complement component 1, q subcomponent, gamma polypeptide | |||
C1R | Complement component 1, r subcomponent | M14058 | M14058 | |
C1S | Complement component 1, s subcomponent | J04080, X06596 | J04080 X06596 | 2 |
C2 | Complement component 2 | X04481 | ||
C3 | Complement component 3 | J04763, K02765 | K02765 | 1 |
C3AR1 | Complement component 3a receptor 1 | U28488, U62027, Z73157 | U62027 | 1 |
C4A | Complement component 4A | K02403, M59815 | K02403 | 2 |
C4B | Complement component 4B | K02404 | ||
C4BPA | Complement component 4-binding protein, alpha | M31452, X02865 | M31452 | |
C4BPAL2 | Complement component 4-binding protein, alpha-like 2 | X81360, X81361, X81362 | ||
C4BPB | Complement component 4-binding protein, beta | L11244, L11245 | L11244 | 1 |
C5 | Complement component 5 | M57729 | M57729 | |
C5R1 | Complement component 5 receptor 1 (C5a ligand) | M62505, X57250 | ||
C6 | Complement component 6 | J05024, J05064 | X72177 | 2 |
C7 | Complement component 7 | J03507 | J03507 | 2 |
C8A | Complement component 8, alpha polypeptide | M16974 | M16974 | 1 |
C8B | Complement component 8, beta polypeptide | M16973, X04393 | M16973 | 1 |
C8G | Complement component 8, gamma polypeptide | M17263, M17999, U08198 | ||
C9 | Complement component 9 | K02766, X02176 | ||
CA1 | Carbonic anhydrase I | M33987 | M33987 | |
CA2 | Carbonic anhydrase II | J03037, M77181 | J03037 | 1 |
CACNA1S | Calcium channel, voltage-dependent, L type, alpha 1S subunit | L33798, U30707 | ||
CACNB2 | Calcium channel, voltage-dependent, beta 2 subunit | U07139 | U07139 | |
CALCA | Calcitonin/calcitonin-related polypeptide, alpha | M26095, X00356, X03662, X15943 | ||
CALCR | Calcitonin receptor | U26553 | ||
CAMP | Cathelicidin antimicrobial peptide | U48795, X96735, Z38026 | Z38026 | |
CAPG | Capping protein (actin filament), gelsolin-like | M94345 | M94345 | 2 |
CAPN3 | Calpain, large polypeptide L3 | X85030 | X85030 | |
CASP1 | Caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) | M87507, U13697 | M87507 | |
CASP10 | Caspase 10, apoptosis-related cysteine protease | U60519 | U60519 | |
CASP2 | Caspase 2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2) | U13022 | ||
CASP3 | Caspase 3, apoptosis-related cysteine protease | U13737, U13738 | U13737 | 2 |
CASP4 | Caspase 4, apoptosis-related cysteine protease | U25804, Z48810 | U28014 | 1 |
CASP5 | Caspase 5, apoptosis-related cysteine protease | U28015 | ||
CASP6 | Caspase 6, apoptosis-related cysteine protease | U20536 | U20536 | 1 |
CASP7 | Caspase 7, apoptosis-related cysteine protease | U37448 | U67319 | |
CASP8 | Caspase 8, apoptosis-related cysteine protease | U60520, X98172 | X98173 | 1 |
CASP9 | Caspase 9, apoptosis-related cysteine protease | U56390, U60521 | U60521 | 1 |
CASR | Calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe neonatal hyperparathyroidism) | D50855, U20759, U20760 | U20760 | 2 |
CAT | Catalase | X04076, X04085 | X04085 | 2 |
CAV3 | Caveolin 3 | AF043101 | AF043101 | 2 |
CBBM | Blue-monochromatic colorblindness (blue cone monochromacy) | |||
CBFA2 | Core-binding factor, runt domain, alpha subunit 2 (acute myeloid leukemia 1; aml1 oncogene) | X79549, X90978 | ||
CBFA2T1 | Core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | D14820, D43638 | D43638 | 1 |
CBFA2T2 | Core-binding factor, runt domain, alpha subunit 2; translocated to, 2 | AF013970, AF052210, AF052211, AF052212 | AF013970 | |
CBFA2T3 | Core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | AF052213, AF052214, AF052215, AF052216, AF052217 | ||
CBFB | Core-binding factor, beta subunit | L20298 | L20298 | |
CBLN1 | Cerebellin 1 precursor | M58583 | M58583 | |
CBR1 | Carbonyl reductase 1 | J04056 | AB003151 | 1 |
CBS | Cystathionine-beta-synthase | L14577, L19501, X82166, AF042836 | L00972 | 1 |
CBX4 | Chromobox homolog 4 (Drosophila Pc class) | AF013956 | ||
CCAL1 | Chondrocalcinosis 1 (calcium pyrophosphate-deposition disease, early onset osteoarthritis) | |||
CCR1 | Chemokine (C-C motif) receptor 1 | D10925, L09230 | D10925 | |
CCR1 | Chemokine (C-C motif) receptor 1 | D10925, L09230 | D10925 | |
CCR2 | Chemokine (C-C motif) receptor 2 | U03882, U03905, U80924, U95626 | U95626 X53961 | 1 |
CCR3 | Chemokine (C-C motif) receptor 3 | U28694 | ||
CCR3 | Chemokine (C-C motif) receptor 3 | U28694 | ||
CCR4 | Chemokine (C-C motif) receptor 4 | X85740 | ||
CCR5 | Chemokine (C-C motif) receptor 5 | U54994, U57840, U95626, AF031237 | U95626 X53961 | 1 |
CCR5 | Chemokine (C-C motif) receptor 5 | U54994, U57840, U95626, AF031237 | U95626 X53961 | 1 |
CCR6 | Chemokine (C-C motif) receptor 6 | U68030, U68032, Z79784 | U45984 | |
CCR7 | Chemokine (C-C motif) receptor 7 | L08176, L31581, L31584 | ||
CCR7 | Chemokine (C-C motif) receptor 7 | L08176, L31581, L31584 | ||
CCR8 | Chemokine (C-C motif) receptor 8 | Z79782 | ||
CD14 | CD14 antigen | X13334 | X13334 | 1 |
CD151 | CD151 antigen | D29963 | D29963 | Location 1 (1) Location 2 (1) |
CD19 | CD19 antigen | M21097, M28170 | ||
CD1A | CD1A antigen, a polypeptide | M27735, M28825, X04450 | ||
CD1B | CD1B antigen, b polypeptide | AH002634 | ||
CD2 | CD2 antigen (p50), sheep red blood cell receptor | M16445 | M16336 | |
CD20 | CD20 antigen | L23418 | ||
CD22 | CD22 antigen | X52785, X59350 | X59350 | |
CD36 | CD36 antigen (collagen type I receptor, thrombospondin receptor) | L06850, M24795, M98398, M98399, S67532 | M98399 | Location 1 (1) Location 2 (1) |
CD36L1 | CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 1 | Z22555 | Z22555 | |
CD39 | CD39 antigen | S73813 | S73813 | |
CD3E | CD3E antigen, epsilon polypeptide (TiT3 complex) | X03884 | ||
CD3G | CD3G antigen, gamma polypeptide (TiT3 complex) | X04145 | X06026 | |
CD3Z | CD3Z antigen, zeta polypeptide (TiT3 complex) | J04132 | ||
CD4 | CD4 antigen (p55) | M12807 | U47924 | 2 |
CD44 | CD44 antigen (homing function and Indian blood group system) | L05424, M59040 | L05424 | 1 |
CD47 | CD47 antigen (Rh-related antigen, integrin-associated signal transducer) | X69398 | X69398 | 1 |
CD5 | CD5 antigen (p56-62) | |||
CD53 | CD53 antigen | M37033, M60871 | M37033 | |
CD58 | CD58 antigen, (lymphocyte function-associated antigen 3) | X06296, Y00636 | Y00636 | |
CD59 | CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344) | M27909, M34671 | M84349 | 4 |
CD5L | CD5 antigen-like (scavenger receptor cysteine rich family) | U82812 | U82812 | |
CD6 | CD6 antigen | |||
CD63 | CD63 antigen (melanoma 1 antigen) | M59907 | X62654 | 1 |
CD68 | CD68 antigen | S57235 | S57235 | |
CD69 | CD69 antigen (p60, early T-cell activation antigen) | L07555, Z22576 | Z30426 | |
CD7 | CD7 antigen (p41) | X06180 | ||
CD74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | K01144 | ||
CD79A | CD79A antigen (immunoglobulin-associated alpha) | L32754, M80462, M86921, S75217 | U05259 | |
CD79B | CD79B antigen (immunoglobulin-associated beta) | L27587, M80461, M89957, S52229 | M89957 | 1 |
CD80 | CD80 antigen (CD28 antigen ligand 1, B7-1 antigen) | M83077 | ||
CD81 | CD81 antigen (target of antiproliferative antibody 1) | M33680 | M33680 | 2 |
CD86 | CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) | |||
CD8A | CD8 antigen, alpha polypeptide (p32) | M12824, M12828 | M12824 | |
CDA | Cytidine deaminase | L27943, AF061655, AF061656, AF061657, AF061658 | L27943 | |
CDAN1 | Congenital dyserythropoietic anemia, type I | |||
CDAN2 | Congenital dyserythropoietic anemia, type II | |||
CDC2L1 | Cell division cycle 2-like 1 (PITSLRE proteins) | M37712, U04815 | M37712 | Location 1 (2) Location 2 (1) Location 3 (3) |
CDH12 | Cadherin 12 (N-cadherin 2) | L33477, L34057 | ||
CDK2 | Cyclin-dependent kinase 2 | M68520, X61622, X62071 | M68520 | |
CDK4 | Cyclin-dependent kinase 4 | U37022 | U37022 | |
CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | L25610, L47233 | ||
CDKN1B | Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | S76986, U10906, X84849 | S76988 | |
CDKN1C | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | D64137, U22398 | U22398 | 1 |
CDKN2A | Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | L27211, U12818, U12819, U12820, U38945 | ||
CDKN2C | Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | AF041248 | AF041248 | 2 |
CDR1 | Cerebellar degeneration-related protein (34kD) | M16965, M31423 | ||
CDR2 | Cerebellar degeneration-related protein (62kD) | M63256 | M63256 | |
CDSN | Corneodesmosin | AF030130 | L20815 | |
CDW52 | CDW52 antigen (CAMPATH-1 antigen) | X62466 | X62466 | |
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | X52560 | X52560 | |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | U48865, U48866 | ||
CEL | Carboxyl ester lipase (bile salt-stimulated lipase) | M54994, M94579 | M54994 | |
CELL | Carboxyl ester lipase-like (bile salt-stimulated lipase-like) | L14813, M94580 | ||
CENPB | Centromere protein B (80kD) | X05299 | X05299 | |
CENPC1 | Centromere protein C 1 | M95724 | M95724 | 1 |
CES1 | Carboxylesterase 1 (monocyte/macrophage serine esterase 1) | X52973 | ||
CETP | Cholesteryl ester transfer protein, plasma | M30185, M32998 | M30185 | |
CFTR | Cystic fibrosis transmembrane conductance regulator | M28668, M55106, M55131, S64699 | M55131 | |
CGA | Glycoprotein hormones, alpha polypeptide | V00518, AH007338 | S70585 | 1 |
CHC1 | Chromosome condensation 1 | X06130 | X12654 | |
CHE2 | Cholinesterase (serum) 2 | |||
CHGA | Chromogranin A (parathyroid secretory protein 1) | J03483, J03915 | U03749 | 1 |
CHH | Cartilage-hair hypoplasia | |||
CHIT1 | Chitinase 1 | U29615 | U29615 | |
CHM | Choroideremia (Rab escort protein 1) | M83773, X78121 | ||
CHML | Choroideremia-like (Rab escort protein 2) | X64728 | X64728 | |
CHRM4 | Cholinergic receptor, muscarinic 4 | M16405 | ||
CHRNA1 | Cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) | Y00762 | ||
CHRNA7 | Cholinergic receptor, nicotinic, alpha polypeptide 7 | U40583, U62436, X70297, Y08420, Z23141 | X70297 | |
CHS1 | Chediak-Higashi syndrome 1 | U67615, U70064 | U67615 | 1 |
CISH | Cytokine inducible SH2-containing protein | Z77852 | ||
CKB | Creatine kinase, brain | L47647, M16364, M16451, X15334 | X15334 | 2 |
CKM | Creatine kinase, muscle | M14780 | AC005781 | 3 |
CKN1 | Cockayne syndrome 1 (classical) | U28413 | U28413 | |
CLA1 | Cerebellar ataxia 1 (autosomal recessive) | |||
CLCN1 | Chloride channel 1 , skeletal muscle | Z25587, Z25884 | ||
CLCN4 | Chloride channel 4 | X77197 | X77197 | 1 |
CLCNKB | Chloride channel Kb | Z30644 | ||
CLDN3 | Claudin 3 | AF007189 | AB000714 | 2 |
CLN3 | Ceroid-lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) | U32680 | ||
CLTA | Clathrin, light polypeptide (Lca) | M20471, M20472 | X81636 M20471 | 2 |
CLU | Clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J) | J02908, M25915, M64722, M74816, X14723 | M25915 | 5 |
CMA1 | Chymase 1, mast cell | M64269, M69136 | ||
CMAR | Cell matrix adhesion regulator | X65784 | ||
CMD1A | Cardiomyopathy, dilated 1A (autosomal dominant) | |||
CMKBR9 | Chemokine (C-C motif) receptor 9 | U94888 | ||
CMKBR9 | Chemokine (C-C motif) receptor 9 | U94888 | ||
CMKLR1 | Chemokine-like receptor 1 | L12406, U79526, U79527 | ||
CNC | Carney complex, multiple neoplasia and lentiginosis | |||
CNGA1 | Cyclic nucleotide gated channel alpha 1 | M84741 | S42457 | |
CNK | Cytokine-inducible kinase | U56998 | U56998 | |
CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase | D13146, M19650, X95520 | X95520 D13146 | 1 |
CNTF | Ciliary neurotrophic factor | S72921, X60477, X60478, X60542 | ||
CNTFR | Ciliary neurotrophic factor receptor | M73238 | ||
COIL | Coilin p80 | U06632 | U06632 | 1 |
COL11A2 | Collagen, type XI, alpha 2 | U32169 | AL031228 | 1 |
COL17A1 | Collagen, type XVII, alpha 1 | M91669, U76564, U76565, U76566, U76567, U76568, U76569, U76570, U76571, U76572, U76573, U76574, U76575, U76576, U76577, U76578, U76579, U76580, U76581, U76582, U76583, U76584, U76585, U76586, U76587, U76588, U76589, U76590, U76591, U76592, U76593, U76604 | M91669 | |
COL1A1 | Collagen, type I, alpha 1 | K01228, M32798, Z74615, AF017178 | Z74615 | 3 |
COL1A2 | Collagen, type I, alpha 2 | J03464, Z74616, AF004877 | ||
COL2A1 | Collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital) | L10347, X06268 | L10347 | |
COL3A1 | Collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) | X06700, X14420 | X14420 | 2 |
COL4A1 | Collagen, type IV, alpha 1 | M11315 | M26576 | 3 |
COL4A3 | Collagen, type IV, alpha 3 (Goodpasture antigen) | M81379, M92993, U02520, X80031 | ||
COL5A1 | Collagen, type V, alpha 1 | D90279, M76729 | M76729 | 2 |
COL7A1 | Collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) | L02870, L06862 | L02870 | |
COL9A2 | Collagen, type IX, alpha 2 | M95610, AF019406 | M95610 | |
COMT | Catechol-O-methyltransferase | M58525, M65212, M65213 | M58525 | 5 |
COX4 | Cytochrome c oxidase subunit IV | M21575, M34600, X54802 | AF005889 | |
CP | Ceruloplasmin (ferroxidase) | M13699 | M13699 | |
CP20 | Lymphocyte cytosolic protein, molecular weight 20kD | |||
CPE | Carboxypeptidase E | X51405 | X51405 | 1 |
CPM | Carboxypeptidase M | J04970 | J04970 | |
CPO | Coproporphyrinogen oxidase (coproporphyria, harderoporphyria) | D16611, Z28409 | D16611 | 1 |
CPS1 | Carbamoyl-phosphate synthetase 1, mitochondrial | D90282, Y15793 | D90282 | 1 |
CR1 | Complement component (3b/4b) receptor 1, including Knops blood group system | X05309, X14362, Y00816 | L17418 | |
CR1L | Complement component (3b/4b) receptor 1-like | M31230, M31231, M31232, M31233, M31234, M31235, M31236, M31237 | ||
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | J03565, M26004 | J03565 | |
CREB1 | CAMP responsive element binding protein 1 | M27691 | M27691 | |
CREBL1 | CAMP responsive element binding protein-like 1 | U31903 | U89337 X98054 | 2 |
CREM | CAMP responsive element modulator | D14826, S68271 | D14825 | |
CRP | C-reactive protein, pentraxin-related | M11880, M11881, M11882, X56214, X56692 | X56692 | 1 |
CRS1C | Cryptidin-related sequence-1C | |||
CRX | Cone-rod homeobox | AF024711 | ||
CRYAB | Crystallin, alpha B | M24906, M28638, S45630 | S45630 | 1 |
CSBP1 | Cytokine suppressive anti-inflammatory drug binding protein 1 (p38 MAP kinase) | L35263 | L35263 | 1 |
CSE1L | Chromosome segregation 1 (yeast homolog)-like | U33286 | AF053641 | 2 |
CSF1 | Colony stimulating factor 1 (macrophage) | M27087, M37435, M76453, X05825, X17648, AH005300 | M37435 X17648 | |
CSF1 | Colony stimulating factor 1 (macrophage) | M27087, M37435, M76453, X05825, X17648, AH005300 | M37435 X17648 | |
CSF1R | Colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog | U63963, X03663 | X03663 D83778 | Location 1 (2) Location 2 (1) |
CSF2 | Colony stimulating factor 2 (granulocyte-macrophage) | M10663, M11220, M11734 | ||
CSF2RA | Colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | M73832, S48475, S48539 | ||
CSF2RB | Colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | M59941 | ||
CSF2RY | Granulocyte-macrophage colony-stimulating factor receptor, alpha | |||
CSF3 | Colony stimulating factor 3 (granulocyte) | X03438, X03655 | ||
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | M59818, M59819, M59820, X55720, X55721 | M59820 | |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | M59818, M59819, M59820, X55720, X55721 | M59820 | |
CSH1 | Chorionic somatomammotropin hormone 1 (placental lactogen) | J00118, J03071, V00573 | ||
CSMF | Chondrosarcoma, extraskeletal myxoid, fused to EWS in | |||
CSN1 | Casein, alpha | X78416 | ||
CSN2 | Casein, beta | X13766, X17070, AF027807 | ||
CSNU3 | Cystinuria type 3 | |||
CSPG2 | Chondroitin sulfate proteoglycan 2 (versican) | U26555, X15998 | ||
CSPG3 | Chondroitin sulfate proteoglycan 3 (neurocan) | AF026547 | AF026547 | |
CSRP1 | Cysteine and glycine-rich protein 1 | M33146 | M33146 | 1 |
CSRP2 | Cysteine and glycine-rich protein 2 (LIM domain only, smooth muscle) | U57646 | U57646 | |
CST3 | Cystatin C (amyloid angiopathy and cerebral hemorrhage) | X05607, X52255 | X52255 | 4 |
CSTB | Cystatin B (stefin B) | U46692 | U46692 | 3 |
CTF1 | Cardiotrophin 1 | U43030 | U43030 | |
CTGF | Connective tissue growth factor | M92934, U14750 | M92934 | 3 |
CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 | L15006, M37245, X15070, X15071 | ||
CTNS | Cystinosis, nephropathic | AJ222967 | AJ222967 | |
CTSB | Cathepsin B | L16510, M14221 | ||
CTSC | Cathepsin C | X87212 | X87212 | |
CTSF | Cathepsin F | AF071748, AF071749, AF088886 | AF071748 | 2 |
CTSG | Cathepsin G | J04990, M16117 | M16117 | |
CTSK | Cathepsin K (pycnodysostosis) | U13665, X82153 | X82153 | 1 |
CTSL | Cathepsin L | M20496, X12451 | X12451 | 2 |
CTSS | Cathepsin S | S93414, U07369, U07370, U07371, U07372, U07373, U07374, AH005369 | M90696 | |
CUBN | Cubilin (intrinsic factor-cobalamin receptor) | AF034611 | ||
CX3CR1 | Chemokine (C-X3-C) receptor 1 | U28934 | U20350 | |
CXCR4 | Chemokine (C-X-C motif), receptor 4 (fusin) | D10924, X71635, AF005058 | AF005058 | |
CYBA | Cytochrome b-245, alpha polypeptide | M21186, M61106, M61107, M62817, M62818, AH002664 | M21186 | Location 1 (2) Location 2 (1) |
CYBB | Cytochrome b-245, beta polypeptide (chronic granulomatous disease) | X04011 | X04011 | |
CYP11A | Cytochrome P450, subfamily XIA (cholesterol side chain cleavage) | M14565, M28253 | M14565 | |
CYP11B2 | Cytochrome P450, subfamily XIB (steroid 11-beta-hydroxylase), polypeptide 2 | D13752, X54741 | ||
CYP17 | Cytochrome P450, subfamily XVII (steroid 17-alpha-hydroxylase), adrenal hyperplasia | M14564, M19489 | M14564 | |
CYP19 | Cytochrome P450, subfamily XIX (aromatization of androgens) | J04127, M22246 | X13589 | 2 |
CYP1A2 | Cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 2 | L00389, M55053, Z00036 | ||
CYP1B1 | Cytochrome P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile) | U03688 | U03688 | 2 |
CYP21 | Cytochrome P450, subfamily XXI (steroid 21-hydroxylase, congenital adrenal hyperplasia) | M17252, X58906 | ||
CYP27A1 | Cytochrome P450, subfamily XXVIIA (steroid 27-hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1 | M62401, X59812 | X59812 | |
CYP2A | Cytochrome P450, subfamily IIA (phenobarbital-inducible) | X06401 | ||
CYP2A6 | Cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 6 | K03192, M33318 | ||
CYP2C9 | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9 | M61855 | M61855 | |
CYP2D@ | Cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing) cluster | |||
CYP2E | Cytochrome P450, subfamily IIE (ethanol-inducible) | J02625, J02843, S77873 | J02625 | |
CYP7A1 | Cytochrome P450, subfamily VIIA (cholesterol 7 alpha-monooxygenase), polypeptide 1 | L13460, M89803, X56088 | ||
D2S69E | T-lymphocyte activation gene 519 | |||
D6S207E | Minor histocompatibility antigen HA-2 | |||
D6S2244E | Ke4 gene, mouse, human homolog of | |||
D6S231E | DEK gene | X64229 | X64229 | |
D6S51E | HLA-B associated transcript-2 | M33509 | M33509 | 4 |
D6S52E | HLA-B associated transcript-3 | M33519 | M33519 | 1 |
D6S54E | HLA-B associated transcript-4 | |||
D6S81E | HLA-B associated transcript-1 | Z37166 | Z37166 | 2 |
D6S82E | HLA-B associated transcript-5 | |||
DAD1 | Defender against cell death 1 | D15057 | D15057 | 3 |
DAF | Decay accelerating factor for complement (CD55, Cromer blood group system) | M30142, M31516 | M30142 | |
DAG1 | Dystroglycan 1 (dystrophin-associated glycoprotein 1) | L19711 | L19711 | 5 |
DAO | D-amino-acid oxidase | D11370, X13227 | ||
DAP | Death-associated protein | X76105 | X76105 | 3 |
DAPK1 | Death-associated protein kinase 1 | X76104 | X76104 | |
DAPK3 | Death-associated protein kinase 3 | AB007144 | AB007144 | |
DBH | Dopamine beta-hydroxylase (dopamine beta-monooxygenase) | X13255, X13256, Y00096 | ||
DCC | Deleted in colorectal carcinoma | X76132 | ||
DCP1 | Dipeptidyl carboxypeptidase 1 (angiotensin I converting enzyme) | J04144 | J04144 | 5 |
DCX | Doublecortex; lissencephaly, X-linked (doublecortin) | AF040254, AJ003112 | AJ003112 | |
DDX10 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 10 (RNA helicase) | U28042 | U28042 | |
DDX11 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (S.cerevisiae CHL1-like helicase) | X99583 | U75967 | 3 |
DEFA1 | Defensin, alpha 1, myeloid-related sequence | M26602 | M26602 | 1 |
DEFA4 | Defensin, alpha 4, corticostatin | U18745, X65977 | ||
DEFA5 | Defensin, alpha 5, Paneth cell-specific | M97925 | ||
DEFA6 | Defensin, alpha 6, Paneth cell-specific | M98331, U33317 | ||
DEFB1 | Defensin, beta 1 | U50930, U50931 | U50931 | 1 |
DF | D component of complement (adipsin) | M84526 | M84526 | 2 |
DFFA | DNA fragmentation factor, 45 kD, alpha subunit | U91985 | U91985 | |
DFFB | DNA fragmentation factor, 40 kD, beta subunit | AF064019 | AF064019 | |
DGCR | DiGeorge syndrome chromosome region | |||
DGI1 | Dentinogenesis imperfecta 1 | |||
DHFR | Dihydrofolate reductase | J00140 | J00140 | 1 |
DI | Diego blood group | |||
DIA1 | Diaphorase (NADH) (cytochrome b-5 reductase) | M16462, M28705, M28706, M28707, M28708, M28709, M28710, M28711, M28712, M28713, Y09501 | M28713 | |
DM | Dystrophia myotonica (includes dystrophia myotonia protein kinase) | |||
DMD | Dystrophin (muscular dystrophy, Duchenne and Becker types), includes DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272 | M18533, M63072, M92650, X14298, X15149 | M18533 | |
DMP1 | Dentin matrix acidic phosphoprotein | U34037, U65378, U89012 | ||
DNASE1 | Deoxyribonuclease I | D83195 | ||
DNASE1L1 | Deoxyribonuclease I-like 1 | |||
DNASE1L2 | Deoxyribonuclease I-like 2 | U62647 | ||
DNASE1L3 | Deoxyribonuclease I-like 3 | U56814 | U75744 | |
DNASE2 | Deoxyribonuclease II, lysosomal | AB004574, AF045937 | ||
DNTT | Deoxynucleotidyltransferase, terminal | M11722, M22968 | ||
DOCK1 | Dedicator of cyto-kinesis 1 | D50857 | D50857 | 2 |
DPP4 | Dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2) | M74777, U13710, U13711, U13712, U13713, U13714, U13715, U13716, U13717, U13718, U13719, U13720, U13721, U13722, U13723, U13724, U13725, U13726, U13727, U13728, U13729, U13730, U13731, U13732, U13733, U13734, U13735, AH005372 | X60708 | 1 |
DPYD | Dihydropyrimidine dehydrogenase | U09178 | U20938 | |
DRA | Down-regulated in adenoma | L02785 | ||
DRD2 | Dopamine receptor D2 | M29066, X51646 | ||
DRD3 | Dopamine receptor D3 | U25441, U32499 | ||
DRD4 | Dopamine receptor D4 | L12398 | ||
DSG1 | Desmoglein 1 | X56654, AF097935, AJ001716 | X56654 | 1 |
DSG3 | Desmoglein 3 (pemphigus vulgaris antigen) | M76482 | ||
DSP | Desmoplakin (DPI, DPII) | M77830 | ||
DTD | Diastrophic dysplasia | U14528 | U14528 | 1 |
DTNA | Dystrobrevin, alpha | U84540 | ||
DTR | Diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) | M60278 | M60278 | 2 |
DXS423E | Segregation of mitotic chromosomes 1 (SMC1, yeast human homolog of; | |||
DXS435E | A-11 gene | |||
DYS | Dysautonomia (Riley-Day syndrome, hereditary sensory autonomic neuropathy type III) | |||
DYX2 | Dyslexia 2 | |||
E2F1 | E2F transcription factor 1 | M96577 | U47677 | |
EBF | Early B-cell factor | AA504812, AI217339 | ||
ECB2 | ||||
ECGF1 | Endothelial cell growth factor 1 (platelet-derived) | M58602, M63193 | ||
ED1 | Ectodermal dysplasia 1, anhidrotic | U59227, U59228 | AF040628 | 1 |
EDG1 | Endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 | M31210, AF022137 | M31210 | |
EDN1 | Endothelin 1 | J05008, M25380 | J05008 | |
EEC2 | Ectrodactyly, ectodermal dysplasia and cleft lip/palate syndrome 2 | |||
EGR1 | Early growth response 1 | X52541 | X52541 | 1 |
EGR2 | Early growth response 2 (Krox-20 (Drosophila) homolog) | J04076 | J04076 | |
EIF3S6 | Eukaryotic translation initiation factor 3, subunit 6 (48kD) | U62962 | U62962 | 1 |
EIF4G1 | Eukaryotic translation initiation factor 4 gamma, 1 | D12686, AF104913 | AF104913 | |
EIF4G2 | Eukaryotic translation initiation factor 4 gamma, 2 | U73824 | U73824 | 1 |
EIF5A | Eukaryotic translation initiation factor 5A | M23419, U17969 | M23419 | |
EJM1 | Epilepsy, juvenile myoclonic 1 | |||
ELA2 | Elastase 2, neutrophil | D00187, J03545, M20199, M20200, M20201, M20202, M20203, M27783, M34379 | ||
ELANH2 | Protease inhibitor 2 (anti-elastase), monocyte/neutrophil | M93056 | M93056 | 1 |
ELAVL2 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 | U12431 | ||
ELAVL4 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) | M62843, S73887 | M62843 | |
ELN | Elastin (supravalvular aortic stenosis, Williams-Beuren syndrome) | J02948, M16983, M17265, M17266, M17267, M17268, M17269, M17270, M17271, M17272, M17273, M17274, M17275, M17276, M17277, M17278, M17279, M17280, M17281, M17282, M36860, X52896 | M36860 U63721 | 1 |
ENG | Endoglin (Osler-Rendu-Weber syndrome 1) | J05481, X72012 | X72012 | Location 1 (1) Location 2 (2) |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | L12468, L14721 | L12468 | |
EPB41 | Erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) | M14993 | M61733 | |
EPB42 | Erythrocyte membrane protein band 4.2 | M29399, M30646, M30647, M60298 | M60298 | |
EPHA3 | EphA3 | M83941 | ||
EPHX1 | Epoxide hydrolase 1, microsomal (xenobiotic) | J03518, L25878, L25879, L25880, X07936, Y00424 | L25879 | |
EPHX2 | Epoxide hydrolase 2, cytoplasmic | L05779, X97024 | L05779 | 1 |
EPO | Erythropoietin | M11319, X02157, X02158 | ||
EPOR | Erythropoietin receptor | M34986, M60459, S45332 | M60459 | |
EPOR | Erythropoietin receptor | M34986, M60459, S45332 | M60459 | |
EPOR | Erythropoietin receptor | M34986, M60459, S45332 | M60459 | |
EPS15 | Epidermal growth factor receptor pathway substrate 15 | U07707, Z29064 | Z29064 | Location 1 (1) Location 2 (1) |
EPT | Epilepsy, partial | |||
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) | M11730, X03363 | M11730 | |
ERCC1 | Excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) | M13194 | ||
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) | L47234, X52221 | X52221 | 1 |
ERCC3 | Excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) | M31899 | M31899 | |
ERCC4 | Excision repair cross-complementing rodent repair deficiency, complementation group 4 | L76568, L77890, U64315 | U64315 | |
ERCC5 | Excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) | D16305, L20046, X69978 | X69978 | 1 |
ES1 | ES1 (zebrafish) protein, human homolog of | U53003, U53007, Y07572 | U53003 | 1 |
ESB3 | Esterase B3 | |||
ESD | Esterase D/formylglutathione hydrolase | M13450 | M13450 | 2 |
ESR1 | Estrogen receptor 1 | M12674, X03635 | X03635 | |
ESR2 | Estrogen receptor 2 (ER beta) | X99101, AF061054 | ||
ETV4 | Ets variant gene 4 (E1A enhancer-binding protein, E1AF) | D12765 | U18018 | |
ETV6 | Ets variant gene 6 (TEL oncogene) | U11732 | U11732 | |
EYCL3 | Eye color 3 (brown) | |||
F10 | Coagulation factor X | L29433, M22613, AH002727 | L29433 | |
F11 | Coagulation factor XI (plasma thromboplastin antecedent) | M13142 | ||
F12 | Coagulation factor XII (Hageman factor) | M17466 | M31315 | |
F13A1 | Coagulation factor XIII, A1 polypeptide | M14354 | M14539 | 3 |
F13B | Coagulation factor XIII, B polypeptide | M14057, M64554 | ||
F2 | Coagulation factor II (thrombin) | M17262, V00595 | J00307 | |
F2R | Coagulation factor II (thrombin) receptor | M62424 | M62424 | |
F2RL2 | Coagulation factor II (thrombin) receptor-like 2 | U92971 | U92971 | |
F3 | Coagulation factor III (thromboplastin, tissue factor) | J02846, J02931, M16553, M27436 | J02931 | |
F5 | Coagulation factor V (proaccelerin, labile factor) | L32779, M14335, M16967, Z99572 | M16967 | |
F7 | Coagulation factor VII (serum prothrombin conversion accelerator) | J02933, M13232 | ||
F7R | Coagulation factor VII regulator | |||
F8A | Factor VIII associated gene | |||
F8C | Coagulation factor VIIIc, procoagulant component (hemophilia A) | M14113, X01179 | M14113 | |
F9 | Coagulation factor IX (plasma thromboplastic component, Christmas disease, hemophilia B) | M11309 | AL033403 | |
FABP1 | Fatty acid binding protein 1, liver | M10617 | ||
FABP2 | Fatty acid binding protein 2, intestinal | M18079 | ||
FABP6 | Fatty acid binding protein 6, ileal (gastrotropin) | |||
FADD | Fas (TNFRSF6)-associated via death domain | U24231 | X84709 | |
FAH | Fumarylacetoacetate | M55150, X51728 | M55150 | |
FANCA | Fanconi anemia, complementation group A | X99226, Z83067 | X99226 | |
FANCB | Fanconi anemia, complementation group B | |||
FANCC | Fanconi anemia, complementation group C | X66893 | X66893 | 1 |
FANCE | Fanconi anemia, complementation group E | |||
FANCG | Fanconi anemia, complementation group G | U70310 | AC004472 AJ007669 | |
FAT | FAT tumor suppressor (Drosophila) homolog | X87241 | X87241 | |
FBLN1 | Fibulin 1 | X53741 | X53742 | Location 1 (1) Location 2 (1) Location 3 (2) |
FBN1 | Fibrillin 1 (Marfan syndrome) | L13923, X63556 | L13923 | 1 |
FBP1 | Fructose-bisphosphatase 1 | L10320, U21931 | U21931 | 1 |
FCAR | Fc fragment of IgA, receptor for | X54150 | X54150 | |
FCER1A | Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide | X06948 | ||
FCER1B | Fc fragment of IgE, high affinity I, receptor for; beta polypeptide | D10583, M89796 | ||
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23A) | X04772 | ||
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor for (CD64) | M63830, M63831, M63832, M63833, M63834, M63835 | M63835 | 2 |
FCGR1B | Fc fragment of IgG, high affinity Ib, receptor for (CD64) | |||
FCGR1B | Fc fragment of IgG, high affinity Ib, receptor for (CD64) | |||
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor for (CD32) | J03619 | M31932 | Location 1 (1) Location 2 (1) |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor for (CD32) | X52473 | ||
FCGR2C | Fc fragment of IgG, low affinity IIb, receptor for (CD32) | M90737, X17653 | ||
FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor for (CD16) | M24854, X07934 | J04162 | 1 |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor for (CD16) | X16863 | ||
FCN1 | Ficolin (collagen/fibrinogen domain-containing) 1 | D83920 | D83920 | |
FDH | Formaldehyde dehydrogenase | |||
FEA | F9 embryonic antigen | |||
FEB1 | Febrile convulsions 1febrile convulsions 1 | |||
FECH | Ferrochelatase (protoporphyria) | D00726 | D00726 | 2 |
FES | Feline sarcoma (Snyder-Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v-fps) oncogene homolog | X06292 | ||
FGA | Fibrinogen, A alpha polypeptide | J00128, M64982 | ||
FGB | Fibrinogen, B beta polypeptide | J00129, M64983 | J00129 | 2 |
FGF1 | Fibroblast growth factor 1 (acidic) | M13361, X51943 | X59065 | |
FGF9 | Fibroblast growth factor 9 (glia-activating factor) | D14838 | ||
FGFR1 | Fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) | M34185, M34641 | X66945 | |
FGFR3 | Fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) | M58051, M64347 | M64347 | |
FGG | Fibrinogen, gamma polypeptide | X02415 | X02415 | 1 |
FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | M12502, M19722 | M19722 | |
FHR2 | Factor H-related gene 2 | X64877 | ||
FKHR | Forkhead (Drosophila) homolog 1 (rhabdomyosarcoma) | U02310, AF032885 | AF032885 | |
FLG | Filaggrin | M24355, M60502 | ||
FLNB | Filamin B, beta (actin-binding protein-278) | AF042166 | AF043045 | 6 |
FLT3 | Fms-related tyrosine kinase 3 | U02687, Z26652 | ||
FLT3LG | Fms-related tyrosine kinase 3 ligand | U03858, U04806 | ||
FMO1 | Flavin containing monooxygenase 1 | M64082 | M64082 | Location 1 (1) Location 2 (1) |
FMO3 | Flavin containing monooxygenase 3 | M83772, U39960, U39961, U39962, U39963, U39964, U39965, U39966, U39967, AH006707, AL021026 | M83772 AL021026 | |
FN1 | Fibronectin 1 | M10905 | X02761 | Location 1 (2) Location 2 (1) |
FOLR1 | Folate receptor 1 (adult) | J05013, X62753 | U20391 | |
FOS | V-fos FBJ murine osteosarcoma viral oncogene homolog | V01512 | V01512 | Location 1 (1) Location 2 (1) |
FOSB | FBJ murine osteosarcoma viral oncogene homolog B | |||
FPDMM | ||||
FPR1 | Formyl peptide receptor 1 | M60626, M60627 | M60626 | |
FPRL1 | Formyl peptide receptor-like 1 | D10922, M84562, U81501 | ||
FR | Froese blood group | |||
FRAP1 | FK506 binding protein 12-rapamycin associated protein 1 | L34075 | U88966 | |
FRDA | Friedreich ataxia | U43747 | U43747 | 1 |
FRG1 | FSHD region gene 1 | L76159 | L76159 | |
FSHMD1A | Facioscapulohumeral muscular dystrophy 1A | |||
FTL | Ferritin, light polypeptide | M10119 | ||
FTNB | Fertilin beta (a disintegrin and metalloproteinase domain 2) | U52370 | ||
FUCA1 | Fucosidase, alpha-L- 1, tissue | M29877 | M29877 | 1 |
FUCA2 | Fucosidase, alpha-L- 2, plasma | |||
FUT2 | Fucosyltransferase 2 (secretor status included) | D82933 | ||
FUT3 | Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group included) | U27328 | ||
FXR1 | Fragile X mental retardation, autosomal homolog 1 | U25165 | U25165 | 1 |
FY | Duffy blood group | U01839, X85785 | X85785 | 3 |
FYB | FYN-binding protein (FYB-120/130) | AF001862, AF001863 | AF001862 | |
G22P1 | Thyroid autoantigen 70kD (Ku antigen) | J04607, J04611 | J04611 | 1 |
G6PD | Glucose-6-phosphate dehydrogenase | M12996, M21248, X03674, X55448 | X03674 X55448 | Location 1 (1) Location 2 (1) |
GAA | Glucosidase, alpha; acid (Pompe disease, glycogen storage disease type II) | M34424, Y00839 | X55079 | 2 |
GABRA5 | Gamma-aminobutyric acid (GABA) A receptor, alpha 5 | L08485 | ||
GABRA6 | Gamma-aminobutyric acid (GABA) A receptor, alpha 6 | S81944 | ||
GABRB1 | Gamma-aminobutyric acid (GABA) A receptor, beta 1 | X14767 | ||
GAD2 | Glutamate decarboxylase 2 (pancreatic islets and brain, 65kD) | M74826, M81882 | ||
GALC | Galactosylceramidase (Krabbe disease) | D25283, L23116 | D86181 | 1 |
GALK1 | Galactokinase 1 | L76927, U26401 | L76927 | |
GALT | Galactose-1-phosphate uridylyltransferase | M60091, M96264 | M60091 | |
GANC | Glucosidase, alpha; neutral C | |||
GAS | Gastrin | V00511 | ||
GAS6 | Growth arrest-specific 6 | L13720 | L13720 | |
GATA3 | GATA-binding protein 3 | X55122, X58072 | X58072 | 2 |
GBA | Glucosidase, beta; acid (includes glucosylceramidase) | M19285 | AF023268 U46920 J03060 L29218 | |
GC | Group-specific component (vitamin D binding protein) | L10641, M12654, X03178 | ||
GCDH | Glutaryl-Coenzyme A dehydrogenase | U69141 | U69141 | 2 |
GCGR | Glucagon receptor | L20316 | ||
GCK | Glucokinase (hexokinase 4, maturity onset diabetes of the young 2) | M69051, M88011, M90299 | M90299 | |
GCP | Green cone pigment (color blindness, deutan) | K03494 | ||
GDH | Glucose dehydrogenase | |||
GEM | GTP-binding protein overexpressed in skeletal muscle | U10550 | U10550 | 1 |
GFI1 | Growth factor independent 1 | U67369 | ||
GGCX | Gamma-glutamyl carboxylase | M81592 | L17128 | |
GGT1 | Gamma-glutamyltransferase 1 | J04131 | J05235 | |
GGTA1 | Glycoprotein, alpha-galactosyltransferase 1 | |||
GH1 | Growth hormone 1 | J00148, V00519, V00520 | ||
GH2 | Growth hormone 2 | J03071, M38451 | ||
GHR | Growth hormone receptor | X06562 | M28467 | |
GIF | Gastric intrinsic factor (vitamin B synthesis) | M63154, X76562 | ||
GLA | Galactosidase, alpha | U78027, X14448 | U78027 U01923 | 3 |
GLC1B | Glaucoma 1, open angle, B (adult-onset) | |||
GLCLC | Glutamate-cysteine ligase (gamma-glutamylcysteine synthetase), catalytic (72.8kD) | M90656 | M90656 | |
GLO1 | Glyoxalase I | |||
GLP1R | Glucagon-like peptide 1 receptor | L23503, U01104, U01156, U01157, U10037 | ||
GLRB | Glycine receptor, beta | U33267 | U33267 | |
GLS | Glutaminase | |||
GLUD1 | Glutamate dehydrogenase 1 | X07769 | M20867 | 2 |
GLYB | Glycine B complementing | |||
GLYS1 | Glycosuria 1, renal | |||
GNAQ | Guanine nucleotide binding protein (G protein), q polypeptide | U40038, U43083 | U43083 | |
GNAS1 | Guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1 | M14631, M21142, X04408, X04409, X07036 | X56009 | 7 |
GNB3 | Guanine nucleotide binding protein (G protein), beta polypeptide 3 | M31328 | U47924 M31328 | 2 |
GNL1 | Guanine nucleotide binding protein-like 1 | L25665 | X66436 | |
GOT2 | Glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) | M22632 | M22632 | 2 |
GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | J02940 | ||
GP1BB | Glycoprotein Ib (platelet), beta polypeptide | J03259, U59632 | U59632 L20860 | |
GP9 | Glycoprotein IX (platelet) | M25827, X52997 | ||
GPD2 | Glycerol-3-phosphate dehydrogenase 2 (mitochondrial) | U12424, U36310 | U36310 | |
GPR10 | G protein-coupled receptor 10 | U32672 | ||
GPR13 | G protein-coupled receptor 13 | U20350 | U20350 | |
GPR15 | G protein-coupled receptor 15 | U34806 | ||
GPR2 | G protein-coupled receptor 2 | U13667 | ||
GPR30 | G protein-coupled receptor 30 | U63917 | ||
GPR4 | G protein-coupled receptor 4 | U21051 | U21051 | |
GPR5 | G protein-coupled receptor 5 | L36149 | ||
GPR9 | G protein-coupled receptor 9 | U32674 | ||
GPT | Glutamic-pyruvate transaminase (alanine aminotransferase) | U70732 | U70732 | |
GPX1 | Glutathione peroxidase 1 | M21304, Y00433 | Y00433 | |
GPX2 | Glutathione peroxidase 2 (gastrointestinal) | X68314 | X68314 | |
GRB10 | Growth factor receptor-bound protein 10 | D86962, U69276, AF073363, AF073364, AF073365, AF073366, AF073367, AF073368, AF073369, AF073370, AF073371, AF073372, AF073373, AF073374, AF073375, AF073376, AF073377, AF073378 | D86962 | |
GRB14 | Growth factor receptor-bound protein 14 | L76687 | L76687 | 1 |
GRIK1 | Glutamate receptor, ionotropic, kainate 1 | L19058, U16125 | ||
GRIK2 | Glutamate receptor, ionotropic, kainate 2 | S75105, U16126 | U16126 | |
GRL | Glucocorticoid receptor | M10901, M11050, U01351, X03225, X03348 | M10901 | |
GRO1 | GRO1 oncogene (melanoma growth stimulating activity, alpha) | X12510 | X54489 | |
GRO2 | GRO2 oncogene | M36820, M57731 | M36820 | 1 |
GRO3 | GRO3 oncogene | M36821, X53800 | ||
GRPR | Gastrin-releasing peptide receptor | M73481 | ||
GSN | Gelsolin (amyloidosis, Finnish type) | X04412 | X04412 | 2 |
GSPT1 | G1 to S phase transition 1 | X17644 | X17644 | |
GSR | Glutathione reductase | X15722 | ||
GSS | Glutathione synthetase | U34683 | U34683 | 1 |
GSTA1 | Glutathione S-transferase A1 | L13269 | ||
GSTA2 | Glutathione S-transferase A2 | M15872, M21758 | M16594 | Location 1 (1) Location 2 (1) |
GSTA4 | Glutathione S-transferase A4 | Y13047, AF020918 | AF025887 | 1 |
GSTM1 | Glutathione S-transferase M1 | J03817 | X08020 | |
GSTM2 | Glutathione S-transferase M2 (muscle) | M63509 | M63509 | |
GSTM3 | Glutathione S-transferase M3 (brain) | J05459 | AF043105 | 1 |
GSTP1 | Glutathione S-transferase pi | U12472 | U12472 | 1 |
GSTT1 | Glutathione S-transferase theta 1 | X79389 | Z84718 | 1 |
GTF2H2 | General transcription factor IIH, polypeptide 2 (44kD subunit) | Z30094 | ||
GTS | Gilles de la Tourette syndrome | |||
GUCY1A3 | Guanylate cyclase 1, soluble, alpha 3 | X66534, Y15723 | Y15723 | |
GUCY2D | Guanylate cyclase 2D, membrane (retina-specific) | L26921, M92432 | ||
GUSB | Glucuronidase, beta | M15182 | M15182 | 1 |
GYPA | Glycophorin A (includes MN blood group) | L31860, M12857, X08054, X51798 | L31860 | |
GYPB | Glycophorin B (includes Ss blood group) | J02982 | J02982 | 1 |
GYS1 | Glycogen synthase 1 (muscle) | J04501 | J04501 | |
GZMA | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | M18737 | M18737 | |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | J03072, M17016, M38193 | ||
GZMM | Granzyme M (lymphocyte met-ase 1) | L36936 | ||
H142T | Temperature sensitivity complementation, H142 | |||
HADHA | Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit | D16480 | D16480 | 4 |
HADHSC | L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain | X96752 | X96752 | |
HAGH | Hydroxyacyl glutathione hydrolase; glyoxalase 2 | X90999 | X90999 | |
HAL | Histidine ammonia-lyase | D16626, D43619 | D16626 | |
HBA1 | Hemoglobin, alpha 1 | J00153, V00491, V00493 | M24173 | |
HBB | Hemoglobin, beta | L48217, M11428, M25113, U01317, V00497, V00500 | V00497 U01317 | |
HBG1 | Hemoglobin, gamma A | M91036, U01317, X55655 | V00497 U01317 | |
HBZ | Hemoglobin, zeta | M24173 | M24173 | |
HCF2 | Heparin cofactor II | M12849 | M58600 | 2 |
HCFC1 | Host cell factor C1 (VP16-accessory protein) | X79198 | U52112 | |
HCR | Chemokine receptor | U97123 | U95626 | |
HD | Huntingtin (Huntington disease) | L12392, L20431 | L12392 | |
HDAC1 | Histone deacetylase 1 | D50405 | D50405 | |
HEXA | Hexosaminidase A (alpha polypeptide) | M16424 | M16424 | |
HEXB | Hexosaminidase B (beta polypeptide) | M13519, M23294 | M23294 | |
HF1 | H factor 1 (complement) | Y00716 | ||
HFE | Hemochromatosis | U60319 | U60319 | 1 |
HFL1 | H factor (complement)-like 1 | M65292, M65293, X56209 | ||
HGF | Hepatocyte growth factor (hepapoietin A; scatter factor) | M29145, M60718, M73239, X16323 | X16323 | |
HGL | Heregulin, alpha (45kD, ERBB2 p185-activator) | M94165, AF026146 | AF009227 | |
HIP1 | Huntingtin interacting protein 1 | U79734 | AF052288 | |
HIVEP1 | Human immunodeficiency virus type I enhancer-binding protein 1 | M32019, X51435 | X51435 | 1 |
HK1 | Hexokinase 1 | M75126, X66957 | AF016365 | 4 |
HK2 | Hexokinase 2 | Z46376 | Z46376 | |
HK3 | Hexokinase 3 (white cell) | U51333 | ||
HLA-A | Major histocompatibility complex, class I, A | U03754 | AF055066 D32129 | Location 1 (2) Location 2 (2) Location 3 (1) |
HLA-B | Major histocompatibility complex, class I, B | M59840 | ||
HLA-C | Major histocompatibility complex, class I, C | M59865 | ||
HLA-DMA | Major histocompatibility complex, class II, DM alpha | X62744 | X57522 Z14982 X62744 U15085 Z14977 X03066 M16276 | Location 1 (3) Location 2 (1) Location 3 (1) Location 4 (1) Location 5 (2) |
HLA-DMB | Major histocompatibility complex, class II, DM beta | U15085 | X57522 Z14982 X62744 U15085 Z14977 X03066 M16276 | Location 1 (3) Location 2 (1) Location 3 (1) Location 4 (1) Location 5 (2) |
HLA-DNA | Major histocompatibility complex, class II, DN alpha | M26039, M31525 | ||
HLA-DOB | Major histocompatibility complex, class II, DO beta | M26040, X03066 | X57522 Z14982 X62744 U15085 Z14977 X03066 M16276 | Location 1 (3) Location 2 (1) Location 3 (1) Location 4 (1) Location 5 (2) |
HLA-DPA1 | Major histocompatibility complex, class II, DP alpha 1 | |||
HLA-DPB1 | Major histocompatibility complex, class II, DP beta 1 | M28200, M83664 | M83664 | Location 1 (1) Location 2 (2) |
HLA-DQA1 | Major histocompatibility complex, class II, DQ alpha 1 | M26041, M33906 | M33906 | Location 1 (9) Location 2 (1) |
HLA-DQB1 | Major histocompatibility complex, class II, DQ beta 1 | M17955, M24364, M60028 | M24364 | |
HLA-DRA | Major histocompatibility complex, class II, DR alpha | |||
HLA-DRB1 | Major histocompatibility complex, class II, DR beta 1 | M32578, M33600, X02902, X03069 | M32578 | 1 |
HLA-E | Major histocompatibility complex, class I, E | M20022, X56841 | X56841 | Location 1 (3) Location 2 (2) |
HLA-F | Major histocompatibility complex, class I, F | |||
HLA-G | HLA-G histocompatibility antigen, class I, G | M32800, X17273 | AF055066 | |
HLALS | Major histocompatibility complex, class I-like sequence (NOTE: symbol provisional) | U22963 | ||
HLCS | Holocarboxylase synthetase (biotin-[proprionyl-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) | D23672 | D87328 | 1 |
HLX1 | H2.0 (Drosophila)-like homeo box 1 | U14325, U14326, U14327, U14328, U14329 | ||
HM74 | Putative chemokine receptor; GTP-binding protein | D10923 | D10923 | |
HMAB | Monocyte antigen B | |||
HMBS | Hydroxymethylbilane synthase | X04217, X04808 | M95623 | |
HMGCL | 3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (hydroxymethylglutaricaciduria) | L07033 | L07033 | 1 |
HMGIC | High-mobility group (nonhistone chromosomal) protein isoform I-C | L46353, U28749, U28754, X92518 | L46353 | 1 |
HMSNL | ||||
HMX1 | Homeo box (H6 family) 1 | M99587 | M99587 | |
HNRPD | Heterogeneous nuclear ribonucleoprotein D | U02019, AF026126 | AF026126 | 1 |
HOXB5 | Homeo box B5 | M92299 | M92299 | 1 |
HOXD13 | Homeo box D13 | AF005219 | ||
HOXD8 | Homeo box D8 | |||
HP | Haptoglobin | M69197, X00637 | X00442 | 1 |
HPE1 | Holoprosencephaly 1, alobar | |||
HPN | Hepsin (transmembrane protease, serine 1) | M18930, X07002, X07732 | X07732 | |
HPR | Haptoglobin-related protein | M69197 | X00442 | 1 |
HPRT1 | Hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome) | M31642, V00530 | M31642 | |
HPS | Hermansky-Pudlak syndrome | U65676, U96721 | U65676 | |
HPX | Hemopexin | M36796, M36798, M36799, M36800, M36801, M36802, M36803 | M36803 | 1 |
HR | Hairless (mouse) homolog | AF039196 | ||
HRAS | V-Ha-ras Harvey rat sarcoma viral oncogene homolog | V00574 | J00277 | 1 |
HRG | Histidine-rich glycoprotein | M13149 | M13149 | 2 |
HRMT1L1 | HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 1 | U80213 | X99209 | 2 |
HRMT1L2 | HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 2 | |||
HRY | Hairy (Drosophila)-homolog | L19314 | ||
HSD17B3 | Hydroxysteroid (17-beta) dehydrogenase 3 | U05659 | U05659 | |
HSD3B1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | M27137, M35493, S45679 | M38180 | |
HSD3B2 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | M67466, M77144 | ||
HSPA1A | Heat shock 70kD protein 1 | M11717, M24743, M59828 | M11717 | Location 1 (1) Location 2 (1) Location 3 (2) Location 4 (2) |
HSPA1L | Heat shock 70kD protein-like 1 | D85730, M59829 | D85730 | |
HSPA2 | Heat shock 70kD protein 2 | U10149 | ||
HSPA6 | Heat shock 70kD protein 6 (HSP70B') | X51757, X51758 | ||
HSPG2 | Heparan sulfate proteoglycan 2 (perlecan) | M64283, M85289, S76436 | M85289 | 1 |
HTLVR | Human T-cell leukemia virus (I and II) receptor | |||
HTN1 | Histatin 1 | M26664 | ||
HTN3 | Histatin 3 | M18372, M26665 | ||
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A | S71229, X57830 | ||
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C | M81778, U49516 | ||
HTR6 | 5-hydroxytryptamine (serotonin) receptor 6 | L41147 | ||
HTR7 | 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) | L21195 | ||
HVBS6 | Hepatitis B virus integration site 6 | |||
HY | Histocompatibility Y antigen | |||
IARS | Isoleucine-tRNA synthetase | D28473, U04953 | U04953 | |
IBD1 | Inflammatory bowel disease 1 | |||
IBSP | Integrin-binding sialoprotein (bone sialoprotein, bone sialoprotein II) | J05213 | ||
ICAM1 | Intercellular adhesion molecule 1 (CD54), human rhinovirus receptor | J03132, X06990 | M24283 | |
ICAM2 | Intercellular adhesion molecule 2 | X15606 | X15606 | 2 |
ICAM3 | Intercellular adhesion molecule 3 | X69819 | X69711 | |
ICAM4 | Intercellular adhesion molecule 4, Landsteiner-Wiener blood group | L27670, X93093 | ||
ICAM5 | Intercellular adhesion molecule 5, telencephalin | U72671, AF082802 | U72671 | |
ICR5 | Ichthyosis congenita V, Sjogren-Larsson-like | |||
ICS1 | Immotile cilia syndrome 1 | |||
ICT1 | Immature colon carcinoma transcript 1 | |||
IDDM10 | Insulin-dependent diabetes mellitus 10 | |||
IDDM11 | Insulin-dependent diabetes mellitus 11 | |||
IDDM15 | Insulin-dependent diabetes mellitus 15 | |||
IDDM17 | Insulin-dependent diabetes mellitus 17 | |||
IDDM4 | Insulin-dependent diabetes mellitus 4 | |||
IDDM6 | Insulin-dependent diabetes mellitus 6 | |||
IDDM7 | Insulin-dependent diabetes mellitus 7 | |||
IDDMX | Diabetes mellitus, insulin-dependent, X-linked, susceptibility to | |||
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | AF020038 | AF020038 | 3 |
IDS | Iduronate 2-sulfatase (Hunter syndrome) | L40586, M58342 | L13329 X78262 | Location 1 (1) Location 2 (2) |
IDUA | Iduronidase, alpha-L- | M74715 | M95740 | |
IF | I factor (complement) | J02770 | Y00318 | 1 |
IFNA1 | Interferon, alpha 1 | E00175 | ||
IFNA10 | Interferon, alpha 10 | J00209, V00551 | ||
IFNA13 | Interferon, alpha 13 | |||
IFNA2 | Interferon, alpha 2 | J00207, M54886, V00544, V00548, V00549 | ||
IFNAR1 | Interferon (alpha, beta and omega) receptor 1 | J03171, X60459 | J03171 | |
IFNAR2 | Interferon (alpha, beta and omega) receptor 2 | L41942, L41943, L41944, L42237, L42238, L42239, L42240, L42241, L42242, L42243, X77722 | L42243 | Location 1 (1) Location 2 (1) |
IFNG | Interferon, gamma | J00219, V00536, X13274 | ||
IFNGR1 | Interferon gamma receptor 1 | J03143, U19247 | U19247 | 1 |
IFNGR2 | Interferon gamma receptor 2 (interferon gamma transducer 1) | U05875, U05877, U68755 | U05875 | 2 |
IFNR | Interferon production regulator | |||
IGAT | Immune response to synthetic polypeptide--IRGAT | |||
IGER | IgE responsiveness (atopic) | |||
IGES | Immunoglobulin E concentration, serum | |||
IGF1 | Insulin-like growth factor 1 (somatomedin C) | M29644, X57025 | X57025 | 1 |
IGF1R | Insulin-like growth factor 1 receptor | X04434 | X04434 | |
IGF2 | Insulin-like growth factor 2 (somatomedin A) | J03242, M14118, X00910 | J03242 | Location 1 (1) Location 2 (1) Location 3 (3) |
IGF2R | Insulin-like growth factor 2 receptor | J03528, Y00285 | Y00285 | 1 |
IGFBP1 | Insulin-like growth factor binding protein 1 | M20841, M23592, M23593, M23594, M23595, M59316, Y00856 | M59316 | 3 |
IGFBP10 | Insulin-like growth factor binding protein 10 | AF031385 | ||
IGFBP2 | Insulin-like growth factor binding protein 2 (36kD) | M35410, X16302 | X16302 | 1 |
IGFBP3 | Insulin-like growth factor binding protein 3 | M35878 | M35878 | 2 |
IGHA1 | Immunoglobulin alpha 1 | |||
IGHA2 | Immunoglobulin alpha 2 (A2M marker) | |||
IGHE | Immunoglobulin epsilon | |||
IGHG1 | Immunoglobulin gamma 1 (Gm marker) | |||
IGHG2 | Immunoglobulin gamma 2 (Gm marker) | |||
IGHV@ | Immunoglobulin heavy polypeptide, variable region (cluster) | |||
IGJ | Immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | |||
IGKC | Immunoglobulin kappa constant region | |||
IGKV | Immunoglobulin kappa variable region | |||
IGLP1 | Immune response to synthetic polypeptides-1 | |||
IGLP2 | Immune response to synthetic polypeptides-2 | |||
IL10 | Interleukin 10 | M57627, U16720 | M57627 | |
IL10RA | Interleukin 10 receptor, alpha | U00672 | U00672 | 2 |
IL10RA | Interleukin 10 receptor, alpha | U00672 | U00672 | 2 |
IL10RB | Interleukin 10 receptor, beta | U08988, Z17227 | Z17227 | |
IL10RB | Interleukin 10 receptor, beta | U08988, Z17227 | Z17227 | |
IL11 | Interleukin 11 | M57765, M81890 | X58377 | |
IL11RA | Interleukin 11 receptor, alpha | U32324, Z38102 | U32324 | 1 |
IL11RA | Interleukin 11 receptor, alpha | U32324, Z38102 | U32324 | 1 |
IL11RB | Interleukin 11 receptor, beta | |||
IL12A | Interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | M65271, M65291 | ||
IL12B | Interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | M65272, M65290 | ||
IL12RB1 | Interleukin 12 receptor, beta 1 | U03187 | ||
IL12RB2 | Interleukin 12 receptor, beta 2 | U64198 | ||
IL12RB2 | Interleukin 12 receptor, beta 2 | U64198 | ||
IL13 | Interleukin 13 | L06801, U10307 | ||
IL13RA1 | Interleukin 13 receptor, alpha 1 | U62858, Y10659 | Y10659 | |
IL13RA2 | Interleukin 13 receptor, alpha 2 | U70981, X95302 | U70981 | |
IL13RA2 | Interleukin 13 receptor, alpha 2 | U70981, X95302 | U70981 | |
IL15 | Interleukin 15 | U14407, X94222, X94223 | AF031167 | 1 |
IL15RA | Interleukin 15 receptor, alpha | U31628 | U31628 | 1 |
IL15RA | Interleukin 15 receptor, alpha | U31628 | U31628 | 1 |
IL15RB | Interleukin 15 receptor, beta | |||
IL16 | Interleukin 16 (lymphocyte chemoattractant factor) | M90391, U82972 | M90391 | 2 |
IL17 | Interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8) | U32659, Z58820 | ||
IL18 | Interleukin 18 (interferon-gamma-inducing factor) | D49950, U90434 | ||
IL18BP | Interleukin 18 binding protein | AF110798 | ||
IL18R1 | Interleukin 18 receptor 1 | U43672 | ||
IL18RAP | Interleukin 18 receptor accessory protein | AF077346 | ||
IL1A | Interleukin 1, alpha | M15329, M28983, X02531, X02851, X03833, X56086 | M28983 | |
IL1B | Interleukin 1, beta | K02770, M15330, M54933, X02532, X56087 | M15330 | 1 |
IL1R1 | Interleukin 1 receptor, type I | M27492 | M27492 | |
IL1R1 | Interleukin 1 receptor, type I | M27492 | M27492 | |
IL1R2 | Interleukin 1 receptor, type II | X59770 | X59770 | |
IL1RAP | Interleukin 1 receptor accessory protein | AF029213 | AB006537 | |
IL1RL2 | Interleukin 1 receptor-like 2 | U49065 | ||
IL1RN | Interleukin 1 receptor antagonist | M55646, U65590, X52015, X53296, X64532 | U65590 | 1 |
IL2 | Interleukin 2 | J00264, K02056, S77834, U25676, V00564, X01586 | ||
IL2RA | Interleukin 2 receptor, alpha | X01057 | ||
IL2RA | Interleukin 2 receptor, alpha | X01057 | ||
IL2RB | Interleukin 2 receptor, beta | M26062 | M26062 | 1 |
IL2RB | Interleukin 2 receptor, beta | M26062 | M26062 | 1 |
IL2RG | Interleukin 2 receptor, gamma (severe combined immunodeficiency) | D11086, L19546 | D11086 | |
IL2RG | Interleukin 2 receptor, gamma (severe combined immunodeficiency) | D11086, L19546 | D11086 | |
IL3 | Interleukin 3 (colony-stimulating factor, multiple) | M14743 | ||
IL3RA | Interleukin 3 receptor, alpha (low affinity) | M74782 | D49410 | 1 |
IL4 | Interleukin 4 | M13982, M23442 | ||
IL4R | Interleukin 4 receptor | X52425 | ||
IL4R | Interleukin 4 receptor | X52425 | ||
IL5 | Interleukin 5 (colony-stimulating factor, eosinophil) | X04688 | ||
IL5RA | Interleukin 5 receptor, alpha | M75914, M96651, M96652, X61177 | ||
IL5RA | Interleukin 5 receptor, alpha | M75914, M96651, M96652, X61177 | ||
IL6 | Interleukin 6 (interferon, beta 2) | M14584, M18403, M29150, M54894, X04403, X04430, X04602 | X04430 | |
IL6R | Interleukin 6 receptor | M20566, X12830 | M20566 | |
IL6R | Interleukin 6 receptor | M20566, X12830 | M20566 | |
IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | M57230 | M57230 | 1 |
IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | M57230 | M57230 | 1 |
IL7 | Interleukin 7 | J04156 | ||
IL7R | Interleukin 7 receptor | M29696 | AF043129 | |
IL7R | Interleukin 7 receptor | M29696 | AF043129 | |
IL8 | Interleukin 8 | M17017, M26383, Y00787 | M17017 | 1 |
IL8RA | Interleukin 8 receptor, alpha | L19592, U11870 | ||
IL8RB | Interleukin 8 receptor, beta | L19593, M73969, U11869 | ||
IL8RB | Interleukin 8 receptor, beta | L19593, M73969, U11869 | ||
IL9 | Interleukin 9 | M30134, X17543 | ||
IL9R | Interleukin 9 receptor | L39064, M84747 | ||
IL9R | Interleukin 9 receptor | L39064, M84747 | ||
ILF1 | Interleukin enhancer binding factor 1 | U58196 | U58196 | 1 |
ILF2 | Interleukin enhancer binding factor 2, 45kD | U10323 | U10323 | 1 |
ILF3 | Interleukin enhancer binding factor 3, 90kD | U10324 | U10324 | 1 |
IMPA1 | Inositol(myo)-1(or 4)-monophosphatase 1 | X66922, Y11360, Y11361, Y11362, Y11363, Y11364, Y11365, Y11366, Y11367 | AF042729 | 2 |
IMPT1 | Imprinted polyspecific membrane transporter 1 | AF028738 | AF030302 | |
INLU | Lutheran inhibitor, dominant (monoclonal antibody A3D8) | |||
INP10 | Interferon (gamma)-induced cell line; protein 10 from | X02530 | X02530 | 1 |
INPP5D | Inositol polyphosphate-5-phosphatase, 145kD | U57650, X98429 | U57650 | 4 |
INS | Insulin | J00265, X70508 | ||
INSR | Insulin receptor | M10051, X02160 | X02160 | 1 |
IPF1 | Insulin promoter factor 1, homeodomain transcription factor | U30329, U35632, X99894 | ||
IPOX | Intestinal pseudoobstruction, neuronal, primary idiopathic | |||
IRAK1 | Interleukin-1 receptor-associated kinase 1 | L76191 | L76191 U52112 | |
IRAK2 | Interleukin-1 receptor-associated kinase 2 | AF026273 | ||
IRF4 | Interferon regulatory factor 4 | U52682, U52683 | U52682 | 1 |
IRS1 | Insulin receptor substrate 1 | S62539 | S62539 | 1 |
ITGA1 | Integrin, alpha 1 | X68742 | X68742 | |
ITGA2 | Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | X17033 | ||
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B) | J02764, J02963, M18085, M34480, X06831 | ||
ITGA4 | Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | L12002, X16983 | X16983 | |
ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | X06256 | X06256 | 1 |
ITGA6 | Integrin, alpha 6 | S66196, X53586 | X53586 | |
ITGA7 | Integrin, alpha 7 | AF032108 | AF032108 | |
ITGAD | Integrin, alpha D | U40274 | ||
ITGAL | Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | Y00796 | ||
ITGAM | Integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide) | J03925, J04145, M18044, M84477 | ||
ITGAV | Integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | M14648 | M14648 | 1 |
ITGAX | Integrin, alpha X (antigen CD11C (p150), alpha polypeptide) | Y00093 | M81695 | |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | X07979 | ||
ITGB2 | Integrin, beta 2 (antigen CD18 (p95), lymphocyte function-associated antigen 1; macrophage antigen 1 (mac-1) beta subunit) | M15395 | M15395 | 2 |
ITGB3 | Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | M20311 | M35999 | 3 |
ITGB4 | Integrin, beta 4 | X51841 | X53587 | Location 1 (1) Location 2 (1) Location 3 (3) |
ITGB4BP | Integrin beta 4 binding protein | Y11435, AF022229, AF047433 | AF022229 | 2 |
ITGB5 | Integrin, beta 5 | J05633 | J05633 | Location 1 (1) Location 2 (2) Location 3 (1) |
ITGB6 | Integrin, beta 6 | M35198 | ||
ITGB7 | Integrin, beta 7 | M62880 | ||
ITIH1 | Inter-alpha (globulin) inhibitor, H1 polypeptide | X63652 | X69532 | 3 |
ITIH4 | Inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein) | D38535, D38595 | D38535 | |
ITK | IL2-inducible T-cell kinase | S65186 | ||
IVL | Involucrin | M13902, M13903 | ||
JAK1 | Janus kinase 1 (a protein tyrosine kinase) | M64174 | M64174 | |
JAK2 | Janus kinase 2 (a protein tyrosine kinase) | AF005216 | ||
JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | U09607 | ||
JPD | Juvenile periodontitis | |||
JUP | Junction plakoglobin | Z68228 | Z68228 | |
KAL1 | Kallmann syndrome 1 sequence | M97252 | M97252 | |
KARS | Lysyl-tRNA synthetase | D32053 | D32053 | 2 |
KCNA1 | Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | L02750 | L02750 | |
KCNA2 | Potassium voltage-gated channel, shaker-related subfamily, member 2 | L02752 | ||
KCNA3 | Potassium voltage-gated channel, shaker-related subfamily, member 3 | M38217, M85217 | ||
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | M83254 | ||
KCNE1 | Potassium voltage-gated channel, Isk-related family, member 1 | L28168 | ||
KCNJ12 | Potassium inwardly-rectifying channel, subfamily J, member 12 | L36069 | ||
KCNJ3 | Potassium inwardly-rectifying channel, subfamily J, member 3 | U50964 | ||
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | U89364 | AF000571 | 2 |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Y15065, AF033348 | Y15065 | |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | L04947, X61656 | AF035121 | |
KEL | Kell blood group | M64934 | M64934 | |
KHK | Ketohexokinase (fructokinase) | X78678 | X78678 | |
KIR2DL4 | Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 | |||
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | U63834, X06182 | X06182 | 1 |
KLKB1 | Kallikrein B plasma, (Fletcher factor) 1 | G41320, M13143 | ||
KLRC2 | Killer cell lectin-like receptor subfamily C, member 2 | |||
KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | |||
KLRC4 | Killer cell lectin-like receptor subfamily C, member 4 | |||
KLRD1 | Killer cell lectin-like receptor subfamily D, member 1 | |||
KNG | Kininogen | K02566, M11437, M11438, M11521, M11522, M11523, M11524, M11525, M11526, M11527, M11528 | M11437 | 1 |
KPNA1 | Karyopherin alpha 1 (importin alpha 5) | |||
KRAS2 | V-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog | K01912, L00048, M54968, X01669 | M54968 | Location 1 (5) Location 2 (1) |
KRT4 | Keratin 4 | X07695 | X07695 | |
KRT9 | Keratin 9 (epidermolytic palmoplantar keratoderma) | S69510 | ||
KRTHA4 | Keratin, hair, acidic, 4 | |||
KRTHB4 | Keratin, hair, basic, 4 | |||
KSR | Kinase suppressor of ras | U43586 | U43586 | |
L1CAM | L1 cell adhesion molecule (hydrocephalus, stenosis of aqueduct of Sylvius 1, MASA (mental retardation, aphasia, shuffling gait and adducted thumbs) syndrome, spastic paraplegia 1) | M77640, X67912, Z29373 | U52112 | |
LAG3 | Lymphocyte-activation gene 3 | X51985 | X51985 | |
LAG5 | Leukocyte antigen group 5 | |||
LAKL | Lymphokine-activated killer cell ligand | |||
LALBA | Lactalbumin, alpha- | J00270, X05153 | ||
LAMA3 | Laminin, alpha 3 (nicein (150kD), kalinin (165kD), BM600 (150kD), epilegrin) | L34155, X85107 | L34155 | |
LAMC1 | Laminin, gamma 1 (formerly LAMB2) | J03202, M55210, X13939 | M55210 | 2 |
LAMP2 | Lysosomal-associated membrane protein 2 | S79873, U36336, X77196 | U36336 | Location 1 (2) Location 2 (1) |
LAMR1 | Laminin receptor 1 (67kD); Ribosomal protein SA | J03799, M14199, AB007146 | ||
LBP | Lipopolysaccharide-binding protein | M35533 | ||
LCK | Lymphocyte-specific protein tyrosine kinase | M36881, U07236 | X05027 | |
LCN1 | Lipocalin 1 (protein migrating faster than albumin, tear prealbumin) | L14927, M90424, X62418, X67647 | ||
LCN2 | Lipocalin 2 (oncogene 24p3) | X83006, X99133 | X99133 | 2 |
LCP1 | Lymphocyte cytosolic protein 1 (L-plastin) | J02923 | J02923 | 1 |
LCP2 | Lymphocyte cytosolic protein 2 (SH2 domain-containing leukocyte protein of 76kD) | U20158 | U20158 | |
LDHA | Lactate dehydrogenase A | X02152 | X02152 | 4 |
LDLR | Low density lipoprotein receptor (familial hypercholesterolemia) | L00352, AH002776 | L00352 | Location 1 (1) Location 2 (3) |
LECT2 | Leukocyte cell-derived chemotaxin 2 | AB007546 | ||
LEP | Leptin (murine obesity homolog) | D49487, U43653 | D63710 | |
LEPR | Leptin receptor | U43168 | U50748 | Location 1 (2) Location 2 (1) |
LGALS1 | Lectin, galactoside-binding, soluble, 1 (galectin 1) | J04456, M57678, X14829 | J04456 | Location 1 (1) Location 2 (1) |
LGALS3 | Lectin, galactoside-binding, soluble, 3 (galectin 3) | M36682, M57710, S59012, AB006780 | AB006780 | 4 |
LGALS3BP | Lectin, galactoside-binding, soluble, 3 binding protein (galectin 6 binding protein) | L13210, X79089 | L13210 | 1 |
LGALS9 | Lectin, galactoside-binding, soluble, 9 (galectin 9) | Z49107, AB005894 | AB005894 | |
LHB | Luteinizing hormone beta polypeptide | X00264 | ||
LHCGR | Luteinizing hormone/choriogonadotropin receptor | M63108, M73746 | ||
LIF | Leukemia inhibitory factor (cholinergic differentiation factor) | M63420, X13967, AC004264 | X13967 | |
LIFR | Leukemia inhibitory factor receptor | X61615 | X61615 | |
LIFR | Leukemia inhibitory factor receptor | X61615 | X61615 | |
LIG1 | Ligase I, DNA, ATP-dependent | M36067 | M36067 | 1 |
LKN-1 | Chemokine CC-2, | U58914, Z70292 | Z49269 AF088219 | 2 |
LMAN1 | Lectin, mannose-binding, 1 | U09716 | ||
LMO4 | LIM domain only 4 | U24576 | U24576 | |
LNPEP | Leucyl/cystinyl aminopeptidase | D50810, U62768 | D50810 | |
LOX | Lysyl oxidase | M94054, S45875, S78694 | L16895 | |
LPA | Lipoprotein, Lp(a) | X06290 | ||
LPL | Lipoprotein lipase | M15856, X14390 | M15856 | 3 |
LQT2 | Long (electrocardiographic) QT syndrome 2 | U04270 | U04270 | |
LRP1 | Low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) | X13916 | X13916 | |
LRP2 | Low density lipoprotein-related protein 2 | U04441 | ||
LSL | Leptin, serum levels of | |||
LSP1 | Lymphocyte-specific protein 1 | S67783, X55188 | X55188 | Location 1 (2) Location 2 (1) |
LTA | Lymphotoxin alpha (TNF superfamily, member 1) | D12614, M16441 | X02910 D12614 Y14768 | |
LTB4R | Leukotriene b4 receptor (chemokine receptor-like 1) | D89078, U41070 | ||
LTB4R | Leukotriene b4 receptor (chemokine receptor-like 1) | D89078, U41070 | ||
LTC4S | Leukotriene C4 synthase | U09353, U11552, U50136 | U50136 | |
LTF | Lactotransferrin | M18642, M83202, M93150, U07643, X52941, X53961 | U95626 X53961 | 1 |
LTK | Leukocyte tyrosine kinase | D16105, X60702 | ||
LU | Lutheran blood group (Auberger b antigen included) | X80026, X83425 | X83425 | 1 |
LY64 | Lymphocyte antigen 64 (mouse) homolog, radioprotective, 105kD | D83597 | D83597 | |
LY9 | Lymphocyte antigen 9 | L42621 | L42621 | |
LYN | V-yes-1 Yamaguchi sarcoma viral related oncogene homolog | M16038 | M16038 | 1 |
LYZ | Lysozyme (renal amyloidosis) | J03801, X14008 | AB007974 | 3 |
M1S1 | Membrane component, chromosome 1, surface marker 1 (40kD glycoprotein, identified by monoclonal antibody GA733) | X13425, X77753 | X77753 | 5 |
MAB21L1 | Mab-21 (C. elegans)-like 1 | U38810 | U38810 | |
MACAM1 | Mucosal addressin cell adhesion molecule-1 | |||
MADH1 | MAD (mothers against decapentaplegic, Drosophila) homolog 1 | U59912 | U59423 | 1 |
MADH2 | MAD (mothers against decapentaplegic, Drosophila) homolog 2 | AF027964 | U68018 | 1 |
MADH4 | MAD (mothers against decapentaplegic, Drosophila) homolog 4 | U44378 | U44378 | 1 |
MAGEA1 | Melanoma antigen, family A, 1 (directs expression of antigen MZ2-E) | M77481 | ||
MAGEB1 | Melanoma antigen, family B, 1 | U93163 | ||
MAL | Mal, T-cell differentiation protein | M15800 | M15800 | |
MALL | Mal, T-cell differentiation protein-like | |||
MANB | Mannosidase, alpha B, lysosomal | U05572, U60885, U60886, U60887, U60888, U60889, U60890, U60891, U60892, U60893, U60894, U60895, U60896, U60897, U60898, U60899, U68382 | U60899 | 1 |
MAP1B | Microtubule-associated protein 1B | L06237 | L06237 | |
MAPKAPK3 | Mitogen-activated protein kinase-activated protein kinase 3 | U09578, U43784 | U09578 | |
MASP1 | Mannan-binding lectin serine protease 1 (C4/C2 activating component of Ra-reactive factor) | D17525, D28593 | D17525 | |
MAT2A | Methionine adenosyltransferase II, alpha | X68836 | X68836 | 3 |
MATN1 | Matrilin 1, cartilage matrix protein | M55675, M55683 | ||
MATN3 | Matrilin 3 | Y13341, AJ001047, AJ224741 | ||
MBL2 | Mannose-binding lectin (protein C) 2, soluble (opsonic defect) | X15422, X15954, AF080508 | ||
MC1R | Melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) | X67594 | ||
MC2R | Melanocortin 2 receptor (adrenocorticotropic hormone) | X65633 | ||
MCC | Mutated in colorectal cancers | M62397 | ||
MCF2 | MCF.2 cell line derived transforming sequence | J03639 | AL033403 | |
MCP | Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen) | M58050, X59408, Y00651, Y07713 | X59405 | Location 1 (4) Location 2 (1) |
MDF1 | Antigen identified by monoclonal antibody A-3A4 | |||
MDH2 | Malate dehydrogenase 2, NAD (mitochondrial) | T09439, AF047470 | AF047470 | 4 |
MDU1 | Antigen identified by monoclonal antibodies 4F2, TRA1.10, TROP4, and T43 | J02939, J03569 | J02939 | 2 |
ME1 | Malic enzyme 1, soluble | X77244 | U43944 | |
ME2 | Malic enzyme 2, mitochondrial | M55905 | M55905 | |
MEKK1 | MAP/ERK kinase kinase 1 | U29671, AF042838 | ||
MEKK3 | MAP/ERK kinase kinase 3 | U78876 | ||
MEMO1 | Methylation modifier for class I HLA | |||
MEN1 | Multiple endocrine neoplasia I | U93236, U93237 | U93237 | |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | M82962 | ||
MER2 | Antigen identified by monoclonal antibodies 1D12, 2F7 | |||
MFAP2 | Microfibrillar-associated protein 2 | U19718 | U19718 | |
MFAP4 | Microfibrillar-associated protein 4 | L38486 | L38486 | 1 |
MFTS | Migraine, familial typical, susceptibility to | |||
MGCT | ||||
MGI | ||||
MGP | Matrix Gla protein | M55270, M58549, X53331 | X53331 | 3 |
MHC2TA | MHC class II transactivator | U18259, X74301 | U18259 | 1 |
MIC2 | Antigen identified by monoclonal antibodies 12E7, F21 and O13 | M16279, X16996 | M16279 | 3 |
MIC5 | Antigen identified by monoclonal antibody R1 | |||
MIC7 | Antigen identified by monoclonal antibody 28.3.7 | |||
MICA | MHC class I polypeptide-related sequence A | L14848 | X92841 | 1 |
MIF | Macrophage migration inhibitory factor (glycosylation-inhibiting factor) | L10612, M25639, M95775 | L19686 | |
MIG | Monokine induced by gamma interferon | X72755 | X72755 | 2 |
MIR-10 | Leukocyte immunoglobulin-like receptor | AF000574, AF004231, AF011565, AF025528 | AF004231 | |
MITF | Microphthalmia-associated transcription factor | Z29678 | Z29678 | |
MLLT2 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); translocated to, 2 | L13773 | L13773 | |
MLN | Motilin | M30277, M30278, M30279, M30280, M30281, X15396, Y00695 | ||
MLR | Mineralocorticoid receptor (aldosterone receptor) | M16801, AF068616, AF068617, AF068618, AF068619, AF068620, AF068621, AF068622, AF068623 | M16801 | |
MMP12 | Matrix metalloproteinase 12 (macrophage elastase) | L23808 | L23808 | |
MMP13 | Matrix metalloproteinase 13 (collagenase 3) | X75308, X81334 | X75308 | |
MMP14 | Matrix metalloproteinase 14 (membrane-inserted) | Z48481 | Z48481 | |
MMP15 | Matrix metalloproteinase 15 (membrane-inserted) | Z48482 | Z48482 | |
MMP16 | Matrix metalloproteinase 16 (membrane-inserted) | AB009303 | D83646 | |
MMP17 | Matrix metalloproteinase 17 (membrane-inserted) | X89576 | X89576 | |
MMP18 | Matrix metalloproteinase 18 | Y08622 | ||
MMP19 | Matrix metalloproteinase 19 | U38320, U38321 | ||
MMP2 | Matrix metalloproteinase 2 (gelatinase A, 72kD gelatinase, 72kD type IV collagenase) | J03210, M55582, M55583, M55584, M55585, M55586, M55587, M55588, M55589, M55590, M55591, M55592, M55593, M58552 | M55593 | 3 |
MMP20 | Matrix metalloproteinase 20 | AJ003144 | ||
MMP21 | Matrix metalloproteinase 21 | AF055334 | AF056200 | |
MMP3 | Matrix metalloproteinase 3 (stromelysin 1, progelatinase) | J03209, X05232 | X05232 | |
MMP7 | Matrix metalloproteinase 7 (matrilysin, uterine) | L22519, L22520, L22521, L22522, L22523, L22524, X07819, Z11887 | L22524 | 1 |
MMP8 | Matrix metalloproteinase 8 (neutrophil collagenase) | J05556 | ||
MMP9 | Matrix metalloproteinase 9 (gelatinase B, 92kD gelatinase, 92kD type IV collagenase) | J05070 | J05070 | Location 1 (2) Location 2 (1) |
MNG1 | Multinodular goitre 1 | |||
MOG | Myelin oligodendrocyte glycoprotein | U64564, U64565, U64566, U64567, U64568, U64569, U64570, U64571, Z48051 | Z48051 | |
MPL | Myeloproliferative leukemia virus oncogene | M90102, U68159, U68162 | ||
MPO | Myeloperoxidase | J02694, M19507, X04876, X15377 | M19507 | |
MRBC | Monkey RBC receptor | |||
MRC1 | Mannose receptor, C type 1 | J05550, M93192, M93193, M93194, M93195, M93196, M93197, M93198, M93199, M93200, M93201, M93202, M93203, M93204, M93205, M93206, M93207, M93208, M93209, M93210, M93211, M93212, M93213, M93214, M93215, M93216, M93217, M93218, M93219, M93220, M93221 | M93221 | 1 |
MRX20 | Mental retardation, X-linked 20 | |||
MSH3 | MutS (E. coli) homolog 3 | D61397, D61398, D61399, D61400, D61401, D61402, D61403, D61404, D61405, D61406, D61407, D61408, D61409, D61410, D61411, D61412, D61413, D61414, D61415, D61416, D61417, D61418, D61419, J04810, U61981 | U61981 | |
MSLR1 | Macrophage scavenger receptor-like 1 | |||
MSR1 | Macrophage scavenger receptor 1 | D90187, D90188 | D13264 | |
MSS | Marinesco-Sjogren syndrome | |||
MSSE | Multiple self-healing squamous epithelioma | |||
MST1 | Macrophage stimulating 1 (hepatocyte growth factor-like) | L11924, M74178 | U28055 | 2 |
MST1R | Macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | X70040 | X70040 | |
MSX2 | Msh (Drosophila) homeo box homolog 2 | X69295 | X69295 | 1 |
MTCO1 | Cytochrome c oxidase I | |||
MTHFD | 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methylenetetrahydrofolate cyclohydrolase, 10-formyltetrahydrofolate synthetase | J04031 | J04031 | 1 |
MTHFR | 5,10-methylenetetrahydrofolate reductase (NADPH) | U09806, AF105977, AF105978, AF105979, AF105980, AF105981, AF105982, AF105983, AF105984, AF105985, AF105986, AF105987 | ||
MTND2 | NADH dehydrogenase 2 | |||
MTP | Microsomal triglyceride transfer protein (large polypeptide, 88kD) | X59657, X75500, X91148 | X91148 | 1 |
MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | U71285 | ||
MTRR | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase | AF025794 | AF025794 | 5 |
MUC1 | Mucin 1, transmembrane | J05581, J05582, X52228, X52229 | J05582 | |
MUC2 | Mucin 2, intestinal/tracheal | L21998, M94132 | L21998 | |
MUC4 | Mucin 4, tracheobronchial | M64594, AJ000281, AJ000282, AJ010901 | ||
MUL | Mulibrey nanism | |||
MUT | Methylmalonyl Coenzyme A mutase | M22990, M65131 | M65131 | 2 |
MX1 | Myxovirus (influenza) resistance 1, homolog of murine (interferon-inducible protein p78) | M30817, M33882 | M33882 | 1 |
MXI1 | MAX-interacting protein 1 | L07648, U32512, U32513, U32514, U32515 | L07648 | 1 |
MYB | V-myb avian myeloblastosis viral oncogene homolog | M15024, U22376 | U22376 | |
MYBPC3 | Myosin-binding protein C, cardiac | U91629, X84075 | U91629 | |
MYC | V-myc avian myelocytomatosis viral oncogene homolog | J00120, V00568, X00196, X00364 | K02276 | 1 |
MYCL1 | V-myc avian myelocytomatosis viral oncogene homolog 1, lung carcinoma derived | M19720 | M19720 | |
MYD88 | Myeloid differentiation primary response gene (88) | U70451, U84408 | U70451 | 2 |
MYF5 | Myogenic factor 5 | X14894 | ||
MYF6 | Myogenic factor 6 (herculin) | X52011 | X52011 | |
MYO5A | Myosin VA (heavy polypeptide 12, myoxin) | L19401, Y07759, Z22957 | Y07759 | |
MYO9B | Myosin IXB | U42391 | U42391 | |
NAB1 | NGFI-A binding protein 1 (ERG1 binding protein 1) | U47007 | AF045451 | |
NAGA | N-acetylgalactosaminidase, alpha- | M59199, M62783 | M62783 | |
NAIP | Neuronal apoptosis inhibitory protein | U19251 | U80017 | 1 |
NAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha | U39412 | U39412 | 1 |
NAPB | ||||
NAPG | N-ethylmaleimide-sensitive factor attachment protein, gamma | U78107 | U78107 | |
NAT1 | N-acetyltransferase 1 (arylamine N-acetyltransferase) | X17059, AF071552 | D90041 | 1 |
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | D90040, D90042, U23052, U23434 | ||
NB | Neuroblastoma (neuroblastoma suppressor) | |||
NCAM1 | Neural cell adhesion molecule 1 | X16841, X55322 | ||
NCF1 | Neutrophil cytosolic factor 1 (47kD, chronic granulomatous disease, autosomal 1) | M25665, M55067 | M55067 | Location 1 (4) Location 2 (1) |
NCF2 | Neutrophil cytosolic factor 2 (65kD, chronic granulomatous disease, autosomal 2) | M32011, U00776, U00777, U00778, U00779, U00780, U00781, U00782, U00783, U00784, U00785, U00786, U00787, U00788 | ||
NCF4 | Neutrophil cytosolic factor 4 (40kD) | U50720, U50721, U50722, U50723, U50724, U50725, U50726, U50727, U50728, U50729 | ||
NDP | Norrie disease (pseudoglioma) | X65724, X65882 | X65724 | |
NDUFS2 | NADH dehydrogenase (ubiquinone) Fe-S protein 2 (49kD) (NADH-coenzyme Q reductase) | AF050640 | AF050640 | 1 |
NEB | Nebulin | X83957 | X83957 | |
NEU | Neuraminidase | AF040958 | AF040958 | 1 |
NF1 | Neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | D12625, M82814, M89914 | M89914 | |
NF2 | Neurofibromin 2 (bilateral acoustic neuroma) | L11353, S73853, Y18000 | L11353 | |
NFATC1 | Nuclear factor of activated T-cells, cytoplasmic 1 | U08015, U59736 | U59736 | 1 |
NFATC3 | Nuclear factor of activated T-cells, cytoplasmic 3 | L41066 | L41066 | 1 |
NFATC4 | Nuclear factor of activated T-cells, cytoplasmic 4 | L41067 | L41067 | 1 |
NFE2 | Nuclear factor (erythroid-derived 2), 45kD | L24122 | S77763 | |
NFE2L2 | Nuclear factor (erythroid-derived 2)-like 2 | S74017 | S74017 | |
NFIL3 | Nuclear factor, interleukin 3 regulated | S79880, U26173, U26713, X64318 | X64318 | |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | M55643, M58603 | M58603 | |
NFKB2 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | X61498, X61499 | S76638 | |
NFKBIA | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | M69043 | M69043 | 1 |
NFRKB | Nuclear factor related to kappa B binding protein | U08191 | U08191 | |
NFYA | Nuclear transcription factor Y, alpha | M59079, X59711 | X59711 | |
NGFB | Nerve growth factor, beta polypeptide | V01511, X52599 | X52599 | |
NKS1 | Natural killer cell susceptibility 1 | |||
NM | Neutrophil migration | |||
NME1 | Non-metastatic cells 1, protein (NM23A) expressed in | X17620 | X17620 | |
NMOR2 | NAD(P)H menadione oxidoreductase 2, dioxin-inducible | J02888, U07729, U07730, U07731, U07732, U07733, U07734, U07735, U07736 | U07736 | 1 |
NNMT | Nicotinamide N-methyltransferase | U08021, U20970, U20971 | U08021 | |
NOS1 | Nitric oxide synthase 1 (neuronal) | D16408, L02881, U17327 | ||
NOS2A | Nitric oxide synthase 2A (inducible, hepatocytes) | L09210, U05810 | X73029 | 1 |
NOS2B | Nitric oxide synthase 2B | |||
NOS2C | Nitric oxide synthase 2C | |||
NOS3 | Nitric oxide synthase 3 (endothelial cell) | M93718, M95296 | M93718 | |
NOTCH1 | Notch (Drosophila) homolog 1 (translocation-associated) | M73980 | ||
NOTCH4 | Notch (Drosophila) homolog 4 | D63395, U95299 | U95299 | |
NP | Nucleoside phosphorylase | J02672, K02574, M13951, M13952, M13953, X00737 | K02574 | 1 |
NPC1 | Niemann-Pick disease, type C1 | AF002020 | AF002020 | |
NPHP1 | Nephronophthisis 1 (juvenile) | AF023674, AJ001815 | AF023674 | |
NPY1R | Neuropeptide Y receptor Y1 | L07615, M84755, M88461 | M88461 | |
NRAMP1 | Natural resistance-associated macrophage protein 1 (might include Leishmaniasis) | D38171, D50402, D50403, L32185, X82015 | ||
NRAMP2 | Natural resistance-associated macrophage protein 2 | L37347, AB004857, AB015355 | AB004857 | Location 1 (1) Location 2 (1) |
NRAS | Neuroblastoma RAS viral (v-ras) oncogene homolog | X02751 | X02751 | Location 1 (2) Location 2 (3) |
NRL | Neural retina leucine zipper | M81840, U95012 | M95925 | |
NT5 | 5' nucleotidase (CD73) | X55740 | X55740 | 1 |
NTF3 | Neurotrophin 3 | M61180, X53655 | ||
NUCB1 | Nucleobindin 1 | M96824, U31336, U31337, U31338, U31339, U31340, U31341, U31342 | M96824 | 1 |
NUMA1 | Nuclear mitotic apparatus protein 1 | Z11583, Z11584 | Z11584 | 1 |
NURR1 | Nuclear receptor related 1 (transcriptionally inducible) | S77154, X75918 | X75918 | 1 |
OA1 | Ocular albinism 1 (Nettleship-Falls) | Z48804 | Z48804 | |
OAS1 | 2',5'-oligoadenylate synthetase 1 | D00068 | M11810 | 1 |
OAS2 | 2'-5'oligoadenylate synthetase 2 | M87284, M87434 | M87284 | 2 |
OAT | Ornithine aminotransferase (gyrate atrophy) | M12267, M23204, Y07511 | M12267 | 2 |
OCRL | Oculocerebrorenal syndrome of Lowe | M88162, U57627 | U57627 | 2 |
ODC1 | Ornithine decarboxylase 1 | M16650, X16277 | X16277 | 1 |
OGG1 | 8-oxoguanine DNA glycosylase | Y11731, Y13277, AB000410, AF003595 | U88620 | |
OLFR2 | Olfactory receptor 2 | |||
OMG | Oligodendrocyte myelin glycoprotein | M63623, X57436 | M63623 | |
OPA1 | Optic atrophy 1 (autosomal dominant) | |||
OPA3 | Iraqi-Jewish optic atrophy plus (3-methylglutaconicaciduria type 3) | |||
OPLL | ||||
OPRM1 | Opioid receptor, mu 1 | L25119, L29301, AH006705 | ||
OPTA2 | Osteopetrosis, autosomal dominant, type II | |||
OPTB1 | Osteopetrosis, autosomal recessive | |||
OR1D2 | Olfactory receptor, family 1, subfamily D, member 2 | U04678 | ||
ORCTL2 | Beckwith-Wiedemann syndrome chromosome region 1, candidate A; Organic cation transporter-like 2; Imprinted polyspecific membrane transporter 1 | AB012083, AF028738, AF030302, AF037064 | AF030302 | |
ORM1 | Orosomucoid 1 | M13692, X02544 | X02544 | 1 |
ORM2 | Orosomucoid 2 | M21540 | ||
OSM | Oncostatin M | M27286, M27287, M27288, AC004264 | X13967 | |
OTC | Ornithine carbamoyltransferase | D00230, K02100 | K02100 | |
OXT | Oxytocin, prepro- (neurophysin I) | M11186, M25650 | ||
P | P blood group globoside | |||
P1 | P blood group (P one antigen) | |||
P2RX1 | Purinergic receptor P2X, ligand-gated ion channel, 1 | X83688 | ||
P2RY1 | Purinergic receptor P2Y, G-protein coupled, 1 | U42029 | ||
PA2G4 | Proliferation-associated 2G4, 38kD | U59435, AH007267 | U59435 | |
PAC1 | Prostate adenocarcinoma-1 | |||
PACE | Paired basic amino acid cleaving enzyme (furin, membrane associated receptor protein) | X17094 | X17094 | 1 |
PAEP | Progestagen-associated endometrial protein (placental protein 14, pregnancy-associated endometrial alpha-2-globulin, alpha uterine protein) | J04129, M34046 | ||
PAFAH | Platelet-activating factor acetylhydrolase | U20157 | ||
PAFAH1B1 | Platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit (45kD) | L13385, L13386, L13387, L13388, L25107, AH006662 | L13385 | Location 1 (1) Location 2 (2) |
PAFAH1B2 | Platelet-activating factor acetylhydrolase, isoform Ib, beta subunit (30kD) | D63390 | ||
PAFAH2 | Platelet-activating factor acetylhydrolase 2 (40kD) | D87845 | D87845 | |
PAH | Phenylalanine hydroxylase | U49897 | U49897 | |
PAI1 | Plasminogen activator inhibitor, type I | M16006, M22313, M22314, M22315, M22316, M22317, M22318, M22319, M22320, M22321, X12701 | M14083 | Location 1 (3) Location 2 (1) |
PAPPA | Pregnancy-associated plasma protein A | U28727, X68280 | U28727 | 2 |
PAR4 | Protease-activated receptor-4 | |||
PAWR | PRKC, apoptosis, WT1, regulator | U63809 | U63809 | |
PAX2 | Paired box gene 2 | L25597, M89470, U45245, U45247, U45248, U45249, U45250, U45251, U45252, U45253, U45254, U45255 | ||
PAX3 | Paired box gene 3 (Waardenburg syndrome 1) | S69369, U02309, U12258, U12259, U12260, U12261, U12262, U12263 | U02309 | |
PAX8 | Paired box gene 8 | L19606, X69699 | X69699 | 2 |
PCBD | 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) | L41559, L41560, AF082858 | L41559 | 2 |
PCCA | Propionyl Coenzyme A carboxylase, alpha polypeptide | M13572, X14608 | X14608 | 1 |
PCCB | Propionyl Coenzyme A carboxylase, beta polypeptide | X73424 | X73424 | |
PCI | Protein C inhibitor (plasminogen activator inhibitor III) | J02639, M68516, U35464 | M68516 | Location 1 (1) Location 2 (3) |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | L05144, L12760 | L05144 | |
PCM1 | Pericentriolar material 1 | L27841 | L27841 | 1 |
PCNT | Pericentrin | U52962, AB007862 | AB007862 | |
PCTK1 | PCTAIRE protein kinase 1 | X66363 | X66363 | 1 |
PCYT2 | Phosphate cytidylyltransferase 2, ethanolamine | D84307 | D84307 | |
PDB2 | ||||
PDCD2 | Programmed cell death 2 | S78085 | S78085 AL031259 | Location 1 (1) Location 2 (3) |
PDE3B | Phosphodiesterase 3B, cGMP-inhibited | D50625, D50626, D50627, D50628, D50629, D50630, D50631, D50632, D50633, D50634, D50635, D50636, D50637, D50638, D50639, D50640, U38178 | ||
PDE4A | Phosphodiesterase 4A, cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E2) | S75213, U68532, AF069491 | L20965 | |
PDE4B | Phosphodiesterase 4B, cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E4) | L12686, L20966, L20971, U85048 | L20971 | |
PDE7A | Phosphodiesterase 7A | L12052 | L12052 | |
PDES1B | Phosphodiesterase IB | U56976, U86078 | U86078 | |
PDGFA | Platelet-derived growth factor alpha polypeptide | M20488, M20489, M20490, M20491, M20492, M20493, M20494, X03795, X06374 | X06374 | |
PDGFB | Platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | K01913, K01914, K01915, K01916, K01917, M12783 | M12783 | |
PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | D50001, D50002, D50003, D50004, D50005, D50006, D50007, D50008, D50009, D50010, D50011, D50012, D50013, D50014, D50015, D50016, D50017, M21574 | M21574 | |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | J03278, M21616 | J03278 | 2 |
PDHA1 | Pyruvate dehydrogenase (lipoamide) alpha 1 | J03503, L13318 | D90084 | 1 |
PDX1 | Pyruvate dehydrogenase complex, lipoyl-containing component X; E3-binding protein | U82328, AF001437 | U82328 | 2 |
PECAM1 | Platelet/endothelial cell adhesion molecule (CD31 antigen) | L34631, L34632, L34633, L34634, L34635, L34636, L34637, L34638, L34639, L34640, L34641, L34642, L34643, L34644, L34645, L34646, L34647, L34648, L34649, L34650, L34651, L34652, L34653, L34654, L34655, L34656, L34657, M28526 | L34657 | 5 |
PEPC | Peptidase C | |||
PEPD | Peptidase D | J04605 | J04605 | |
PEX10 | Peroxisome biogenesis factor 10 | AF060502 | ||
PF4 | Platelet factor 4 | M25897 | M25897 | 2 |
PF4V1 | Platelet factor 4 variant 1 | M26167 | ||
PFBI | Plasmodium falciparum blood infection levels | |||
PFC | Properdin P factor, complement | M83652, X57748, X70872, AF005664 | AL009172 | |
PFKL | Phosphofructokinase, liver | X15573, X16911, X16912, X16913, X16914, X16915, X16916, X16917, X16918, X16919, X16920, X16921, X16922, X16923, X16924, X16925, X16926, X16927, X16928, X16929, X16930 | X15573 | |
PFKM | Phosphofructokinase, muscle | M26066, M59719, M59720, M59721, M59722, M59723, M59724, M59725, M59726, M59727, M59728, M59729, M59730, M59731, M59732, M59733, M59734, M59735, M59736, M59737, M59738, M59739, M59740, M59741, U24183, Y00698 | M26066 U24183 | 3 |
PFKP | Phosphofructokinase, platelet | D25328, M64784 | D25328 | Location 1 (1) Location 2 (1) Location 3 (1) |
PFN1 | Profilin 1 | J03191 | J03191 | 1 |
PGA3 | Pepsinogen 3, group I (pepsinogen A) | |||
PGC | Progastricsin (pepsinogen C) | J04443, M18659, M18660, M18661, M18662, M18663, M18664, M18665, M18666, M18667, U75272 | M18667 | |
PGD | Phosphogluconate dehydrogenase | U30255 | U30255 | |
PGF | Placental growth factor, vascular endothelial growth factor-related protein | X54936 | X54936 | 2 |
PGK1 | Phosphoglycerate kinase 1 | L00159, L00160, V00572 | V00572 | |
PGK2 | Phosphoglycerate kinase 2 | |||
PGL1 | Paraganglioma or familial glomus tumors 1 | |||
PGM1 | Phosphoglucomutase 1 | M83088 | M83088 | 3 |
PGM3 | Phosphoglucomutase 3 | |||
PGP | Phosphoglycolate phosphatase | |||
PGY1 | P glycoprotein 1/multiple drug resistance 1 | M14758, M29422, M29423, M29424, M29425, M29426, M29427, M29428, M29429, M29430, M29431, M29432, M29433, M29434, M29435, M29436, M29437, M29438, M29439, M29440, M29441, M29442, M29443, M29444, M29445, M29446, M29447, AF016535 | M14758 | |
PHAP1 | Putative human HLA class II associated protein I | X75090 | U73477 | |
PHB | Prohibitin | S85655 | S85655 | |
PI | Protease inhibitor 1 (anti-elastase), alpha-1-antitrypsin | K01396, M11465, V00496, X01683, X02920 | X01683 | Location 1 (3) Location 2 (5) Location 3 (2) |
PI3 | Protease inhibitor 3, skin-derived (SKALP) | S58717, Z18538 | L10343 | |
PI6 | Protease inhibitor 6 (placental thrombin inhibitor) | Z22658 | ||
PI8 | Protease inhibitor 8 (ovalbumin type) | L40377 | ||
PI9 | Protease inhibitor 9 (ovalbumin type) | L40378, U71364 | ||
PIGA | Phosphatidylinositol glycan, class A (paroxysmal nocturnal hemoglobinuria) | D11466, D28787, D28788, D28789, D28790, D28791, S74936 | D11466 | |
PIGF | Phosphatidylinositol glycan, class F | D13435 | D13435 | 1 |
PIGR | Polymeric immunoglobulin receptor | M24559, S62403 | ||
PIK3CA | Phosphoinositide-3-kinase, catalytic, alpha polypeptide | Z29090 | Z29090 | |
PIK3CB | Phosphoinositide-3-kinase, catalytic, beta polypeptide | S67334 | S67334 | |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) | M61906 | M61906 | |
PIL | Protease inhibitor 1 (alpha-1-antitrypsin)-like | M19684, M19685 | ||
PIN | Dynein, cytoplasmic, light polypeptide | U32944 | U32944 | 1 |
PKLR | Pyruvate kinase, liver and RBC | D10326, M15465 | D13243 | 1 |
PLAGL1 | Pleomorphic adenoma gene-like 1 | U81992 | U72621 | 1 |
PLAT | Plasminogen activator, tissue | D01096, M15518, M18182, M26666, X07393, X13097 | M15518 | |
PLCD1 | Phospholipase C, delta 1 | U09117 | U09117 | |
PLCG1 | Phospholipase C, gamma 1 (formerly subtype 148) | M34667 | AL022394 | |
PLEK | Pleckstrin | X07743 | X07743 | 2 |
PLG | Plasminogen | X05199 | M34276 U67178 | 7 |
PLOD | Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase, Ehlers-Danlos syndrome type VI) | L06419 | L06419 | 1 |
PLP | Proteolipid protein (Pelizaeus-Merzbacher disease, spastic paraplegia 2, uncomplicated) | M27110, M54927 | M54927 | |
PLT1 | Primed lymphocyte test-1 | |||
PML | Promyelocytic leukemia | M80185, S50913, X63131 | ||
PMP22 | Peripheral myelin protein 22 | D11428, L03203, M94048 | D11428 | Location 1 (1) Location 2 (3) |
PMS2 | Postmeiotic segregation increased (S. cerevisiae) 2 | U13696 | U14658 | 1 |
PNMT | Phenylethanolamine N-methyltransferase | J03727 | ||
PNUTL1 | Peanut (Drosophila)-like 1 | Y11593, AF006988, AF061152, AF061153, AF061154 | U59632 | |
POLB | Polymerase (DNA directed), beta | D29013 | D29013 | |
POMC | Proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin) | M28636, M38297, V01510 | V01510 | 1 |
PON1 | Paraoxonase 1 | M63012, S64615 | ||
PON2 | Paraoxonase 2 | AF001601 | AF001601 | 2 |
PORC | Porphyria, acute; Chester type | |||
POU2AF1 | POU domain, class 2, associating factor 1 | Z49194 | ||
POU5F1 | POU domain, class 5, transcription factor 1 | Z11899 | ||
PPBP | Pro-platelet basic protein (includes platelet basic protein, beta-thromboglobulin, connective tissue-activating peptide III, neutrophil-activating peptide-2) | M54995 | M54995 | |
PPCD | Posterior polymorphous corneal dystrophy | |||
PPH1 | Primary pulmonary hypertension 1 | |||
PPIB | Peptidylprolyl isomerase B (cyclophilin B) | M60457, M60857, M63573 | M63573 | 1 |
PPOX | Protoporphyrinogen oxidase | D38537 | D38537 | |
PPP1R8 | Protein phosphatase 1, regulatory (inhibitor) subunit 8 | U14575 | U14575 | |
PRB1 | Proline-rich protein BstNI subfamily 1 | K03204, M97220 | ||
PRB2 | Proline-rich protein BstNI subfamily 2 | |||
PRB3 | Proline-rich protein BstNI subfamily 3 | |||
PRB4 | Proline-rich protein BstNI subfamily 4 | K03207 | ||
PREP | Prolyl endopeptidase | X74496 | X74496 | |
PRF1 | Perforin 1 (preforming protein) | M31951, X13224 | ||
PRG1 | Proteoglycan 1, secretory granule | J03223, X12765, X17042 | X17042 | 5 |
PRH1 | Proline-rich protein HaeIII subfamily 1 | |||
PRH2 | Proline-rich protein HaeIII subfamily 2 | K03202, M13058 | ||
PRKCQ | Protein kinase C, theta | L01087 | L01087 | |
PRKDC | Protein kinase, DNA-activated, catalytic polypeptide | L27425, U47077 | U47077 | |
PRKG1 | Protein kinase, cGMP-dependent, type I | Y07512 | ||
PRKM10 | Protein kinase mitogen-activated 10 (MAP kinase) | U07620 | U07620 | |
PRKM9 | Protein kinase mitogen-activated 9 (MAP kinase) | L31951, U34821 | U09759 | 2 |
PRL | Prolactin | J00299, M29386, V00566 | V00566 | |
PRLR | Prolactin receptor | M31661 | M31661 | |
PRNP | Prion protein (p27-30) (Creutzfeld-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia) | D00015, M13899 | U29185 | 1 |
PROC | Protein C (inactivator of coagulation factors Va and VIIIa) | X02750 | X02750 | |
PROP1 | Prophet of Pit1, paired-like homeodomain transcription factor | |||
PROS1 | Protein S (alpha) | M14338, M15036, X12892 | M14338 | |
PRPH | Peripherin | |||
PRSS1 | Protease, serine, 1 (trypsin 1) | M22612 | M22612 | |
PRSS2 | Protease, serine, 2 (trypsin 2) | M27602 | ||
PRSS7 | Protease, serine, 7 (enterokinase) | U09860 | ||
PRSS8 | Protease, serine, 8 (prostasin) | U33446 | L41351 | |
PRTN3 | Proteinase 3 (serine proteinase, neutrophil, Wegener granulomatosis autoantigen) | M29142, M75154, X55668 | ||
PSAP | Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy) | D00422, J03015, J03077, M32221, M86181, X57108 | J03077 | Location 1 (4) Location 2 (1) |
PSD | Pleckstrin and Sec7 domain protein | X99688 | X99688 | |
PSMB8 | Proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional protease 7) | Z14982 | X57522 Z14982 X62744 U15085 Z14977 X03066 M16276 | Location 1 (3) Location 2 (1) Location 3 (1) Location 4 (1) Location 5 (2) |
PSORS1 | Psoriasis susceptibility 1 | |||
PSORS2 | Psoriasis susceptibility 2 | |||
PSORS3 | Psoriasis susceptibility 3 | |||
PTAFR | Platelet-activating factor receptor | D10202, M76674, M80436, S52624 | ||
PTC | Phenylthiocarbamide tasting | |||
PTCH | Patched (Drosophila) homolog | U43148, U59464 | U43148 | |
PTEN | Phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | U92436 | U92436 | |
PTGDS | Prostaglandin D2 synthase (21kD, brain) | M98538, M98539 | M98539 | Location 1 (1) Location 2 (1) |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | D38297, D38298, D38299, D38300, D38301, D86097, L26976, L27488, L27490, S68874, S69200, S69326, U13214, U13215, U13216, U13217, U13218, X83857, X83858, X83859, X83860, X83861, X83862, X83863 | D86096 | |
PTGIR | Prostaglandin I2 (prostacyclin) receptor (IP) | D25418, D29634, L29016 | ||
PTGS1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | M59979, U63846 | M59979 | 1 |
PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | D28235, L15326, M90100, U04636 | U04636 | |
PTK2B | Protein tyrosine kinase 2 beta | L49207, U33284 | U43522 | |
PTN | Pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) | D90226, M57399 | AB004306 | |
PTPN13 | Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | D21210 | ||
PTPN6 | Protein tyrosine phosphatase, non-receptor type 6 | M74903, M77273 | X62055 | |
PTPRC | Protein tyrosine phosphatase, receptor type, c polypeptide | Y00062 | Y00062 | |
PTPRCAP | Protein tyrosine phosphatase, receptor type, c polypeptide-associated protein | X97267 | X97267 | |
PTPRD | Protein tyrosine phosphatase, receptor type, D | L38929, X54133 | L38929 | |
PTPRF | Protein tyrosine phosphatase, receptor type, F | Y00815 | Y00815 | |
PTPRG | Protein tyrosine phosphatase, receptor type, gamma polypeptide | U46116 | U46116 | |
PTX3 | Pentaxin-related gene, rapidly induced by IL-1 beta | M31166 | M31166 | |
PUJO | ||||
PVR | Poliovirus receptor | |||
PVRL1 | Poliovirus receptor-like 1 | X76400 | ||
PVRL2 | Poliovirus receptor-like 2 | X80038 | ||
PXE | Pseudoxanthoma elasticum | |||
PXMP1 | Peroxisomal membrane protein 1 (70kD, Zellweger syndrome) | M81182, X58528 | X83467 | |
PXN | Paxillin | U14588 | D86863 U14588 | |
PYCR1 | Pyrroline-5-carboxylate reductase 1 | |||
PYGM | Phosphorylase, glycogen; muscle (McArdle syndrome, glycogen storage disease type V) | U94777, AF066859 | U94777 | |
QDPR | Quinoid dihydropteridine reductase | M16447, X04882 | M16447 | 1 |
RAC2 | Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | |||
RAC3 | Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | AF008591 | AF008591 | |
RAD17 | RAD17 (S. pombe) homolog | AJ004977 | AJ001642 | |
RAD51L3 | RAD51 (S. cerevisiae)-like 3 | AF034956 | Y15572 | |
RAF1 | V-raf-1 murine leukemia viral oncogene homolog 1 | X03484 | X03484 | 3 |
RAG1 | Recombination activating gene 1 | M29474 | ||
RAG2 | Recombination activating gene 2 | |||
RANBP3 | RAN binding protein 3 | Y08698, AC004602 | Y08698 | |
RAP1A | RAP1A, member of RAS oncogene family | M22995 | M22995 | 1 |
RB1 | Retinoblastoma 1 (including osteosarcoma) | M15400 | L41870 | |
RBP4 | Retinol-binding protein 4, interstitial | |||
RBS | Roberts syndrome | |||
RCN2 | Reticulocalbin 2, EF-hand calcium binding domain | X78669 | X78669 | 1 |
RCP | Red cone pigment (color blindness, protan) | |||
RCV1 | Recoverin | S43855, S62028 | S43855 | |
RDBP | RD RNA-binding protein | |||
RDS | Retinal degeneration, slow (retinitis pigmentosa 7) | M73531 | M73531 | |
RELA | V-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (p65)) | |||
REN | Renin | L00073 | M26901 | |
RENBP | Renin-binding protein | U52112 | U52112 | |
REQ | Requiem, apoptosis response zinc finger gene | AF001433 | AF001433 | 1 |
RFX1 | Regulatory factor X, 1 (influences HLA class II expression) | X58964 | ||
RFX2 | Regulatory factor X, 2 (influences HLA class II expression) | X76091 | ||
RFX3 | Regulatory factor X, 3 (influences HLA class II expression) | X76092 | ||
RFX4 | Regulatory factor X, 4 (influences HLA class II expression) | M69296 | ||
RFX5 | Regulatory factor X, 5 (influences HLA class II expression) | X85786 | X85786 | |
RFXAP | Regulatory factor X-associated protein | Y12812 | Y12812 | |
RGS2 | Regulator of G-protein signalling 2, 24kD | L13391 | L13391 | 2 |
RHCE | Rhesus blood group, CcEe antigens | Z97333 | ||
RHD | Rhesus blood group, D antigen | L08429, Z97026 | X54534 | |
RHO | Rhodopsin (retinitis pigmentosa 4, autosomal dominant) | U49742 | U49742 | 1 |
RMSA1 | Regulator of mitotic spindle assembly 1 | L26953 | L26953 | |
RN5S1@ | RNA, 5S cluster 1 | V00589 | ||
RNR1 | RNA, ribosomal 1 | |||
RNU1A | RNA, U1A small nuclear | |||
RNU2 | RNA, U2 small nuclear | |||
ROM1 | Retinal outer segment membrane protein 1 | L07894, M96759 | M96759 | |
RP2 | Retinitis pigmentosa 2 (X-linked recessive) | |||
RPE65 | Retinal pigment epithelium-specific protein (65kD) | U18991 | ||
RPL7A | Ribosomal protein L7a | M36072, X06705 | M36072 | 4 |
RPS4X | Ribosomal protein S4, X-linked | M22146, M58458, AF041428 | M58458 | Location 1 (1) Location 2 (2) Location 3 (2) |
RRAD | Ras-related associated with diabetes | L24564, U46165 | L24564 | |
RRM1 | Ribonucleotide reductase M1 polypeptide | X59543 | X59543 | 1 |
RSN | Restin (Reed-Steinberg cell-expressed intermediate filament-associated protein) | M97501 | X64838 | 3 |
RTS | Rothmund-Thomson syndrome | |||
RXRB | Retinoid X receptor, beta | |||
RYR1 | Ryanodine receptor 1 (skeletal) | J05200 | ||
S100A4 | S100 calcium-binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog) | M80563 | M80563 | 2 |
S100A7 | S100 calcium-binding protein A7 (psoriasin 1) | M86757 | M86757 | |
S100A8 | S100 calcium-binding protein A8 (calgranulin A) | Y00278 | X06234 | |
SAA1 | Serum amyloid A1 | M23698 | M26152 | |
SAG | S-antigen; retina and pineal gland (arrestin) | U70976 | X12453 | |
SAR1 | RasGAP-like with IQ motifs | D29640 | ||
SCLC1 | ||||
SCN1B | Sodium channel, voltage-gated, type I, beta polypeptide | L10338, L16242 | L10338 | |
SCN4A | Sodium channel, voltage-gated, type IV, alpha polypeptide | L01983, M81758, U24693, AH003201, AH005307 | ||
SCN5A | Sodium channel, voltage-gated, type V, alpha polypeptide (long (electrocardiographic) QT syndrome 3) | M77235 | ||
SCNN1G | Sodium channel, nonvoltage-gated 1, gamma | U48937, X87160 | ||
SCYA1 | Small inducible cytokine A1 (I-309, homologous to mouse Tca-3) | M57502, M57506 | ||
SCYA11 | Small inducible cytokine subfamily A (Cys-Cys), member 11 (eotaxin) | D49372, U46573 | U46573 | |
SCYA13 | Small inducible cytokine subfamily A (Cys-Cys), member 13 | U46767, AJ000979 | U46767 | |
SCYA14 | Small inducible cytokine subfamily A (Cys-Cys), member 14 | Z49269, Z70292 | Z49269 AF088219 | 2 |
SCYA15 | Small inducible cytokine subfamily A (Cys-Cys), member 15 | Z70292 | ||
SCYA16 | Small inducible cytokine subfamily A (Cys-Cys), member 16 | U91746, AB007454, AF055467 | Z49269 AF088219 | 2 |
SCYA17 | Small inducible cytokine subfamily A (Cys-Cys), member 17 | D43767 | AC004382 | |
SCYA18 | Small inducible cytokine subfamily A (Cys-Cys), member 18, pulmonary and activation-regulated | Y13710, AB000221 | AB012113 | 1 |
SCYA19 | Small inducible cytokine subfamily A (Cys-Cys), member 19 | AB000887 | AB000887 | |
SCYA2 | Small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig-je) | M24545, M28226, X14768 | M28225 | 2 |
SCYA20 | Small inducible cytokine subfamily A (Cys-Cys), member 20 | D86955, U64197 | U64197 | |
SCYA21 | Small inducible cytokine subfamily A (Cys-Cys), member 21 | AB002409 | AB002409 | |
SCYA22 | Small inducible cytokine subfamily A (Cys-Cys), member 22 | U83171 | U83171 | |
SCYA23 | Small inducible cytokine subfamily A (Cys-Cys), member 23 | U85767, AF088219 | Z49269 AF088219 | 2 |
SCYA24 | Small inducible cytokine subfamily A (Cys-Cys), member 24 | U85768 | ||
SCYA25 | Small inducible cytokine subfamily A (Cys-Cys), member 25 | U86358 | U86358 | |
SCYA3 | Small inducible cytokine A3 (homologous to mouse Mip-1a) | M23452, M25315, X03754 | D90144 | 1 |
SCYA3L1 | Small inducible cytokine A3-like 1 | |||
SCYA4 | Small inducible cytokine A4 (homologous to mouse Mip-1b) | J04130, M23502, M25316, X16166, X53683 | J04130 | |
SCYA5 | Small inducible cytokine A5 (RANTES) | M21121 | Z49269 AF088219 | 2 |
SCYA7 | Small inducible cytokine A7 (monocyte chemotactic protein 3) | X72308 | X72308 | |
SCYA8 | Small inducible cytokine subfamily A (Cys-Cys), member 8 (monocyte chemotactic protein 2) | X99886 | Y16645 | |
SCYB5 | Small inducible cytokine subfamily B (Cys-X-Cys), member 5 (epithelial-derived neutrophil-activating peptide 78) | X78686 | ||
SCYB6 | Small inducible cytokine subfamily B (Cys-X-Cys), member 6 (granulocyte chemotactic protein 2) | U83303 | ||
SCYC1 | Small inducible cytokine subfamily C, member 1 (lymphotactin) | D43768, U23772, X86474 | D43768 | 1 |
SCYD1 | Small inducible cytokine subfamily D (Cys-X3-Cys), member 1 (fractalkine, neurotactin) | U84487 | AC004382 U84487 | 2 |
SDF1 | Stromal cell-derived factor 1 | L36033, U16752 | L36033 | 2 |
SDHC | Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kD | D49737 | U57877 | 1 |
SELE | Selectin E (endothelial adhesion molecule 1) | M24736 | M25280 AL021940 | Location 1 (1) Location 2 (2) |
SELL | Selectin L (lymphocyte adhesion molecule 1) | X16070, AL021940 | M25280 AL021940 | Location 1 (1) Location 2 (2) |
SELP | Selectin P (granule membrane protein 140kD, antigen CD62) | M25322 | M25322 | |
SELPLG | Selectin P ligand | U02297, U25956 | U25956 | |
SERK1 | SAPK/Erk kinase 1 | L36870, U17743 | L36870 | |
SF | Stoltzfus blood group | |||
SFTPA1 | Surfactant, pulmonary-associated protein A1 | M68519 | M68519 | 4 |
SFTPA2 | Surfactant, pulmonary-associated protein A2 | |||
SFTPB | Surfactant, pulmonary-associated protein B | J02761, M16764, M19097, M24461 | J02761 | 2 |
SFTPD | Surfactant, pulmonary-associated protein D | L05485 | L05485 | |
SGCB | Sarcoglycan, beta (43kD dystrophin-associated glycoprotein) | U31116 | U31116 | |
SGCD | Sarcoglycan, delta (35kD dystrophin-associated glycoprotein) | U58331, X95191 | U58331 | |
SGSH | N-sulfoglucosamine sulfohydrolase (sulfamidase) | U30894 | U30894 | 1 |
SH2D1A | SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome) | AL023657 | AL023657 AL022718 | 1 |
SHH | Sonic hedgehog (Drosophila) homolog | L38518 | ||
SHMT2 | Serine hydroxymethyltransferase 2 (mitochondrial) | U23143 | U23143 | 1 |
SHOX | Short stature homeobox | U82668, Y11536 | ||
SIAH1 | Seven in absentia (Drosophila) homolog 1 | U63295, U76247 | U76247 | 2 |
SIPA1 | Signal-induced proliferation-associated gene 1 | |||
SKIV2L | Superkiller viralicidic activity 2 (S. cerevisiae homolog)-like | |||
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporters), member 1 | U58130 | ||
SLC14A1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | |||
SLC18A2 | Solute carrier family 18 (vesicular monoamine), member 2 | L09118, L14269, L23205, X71354 | L14269 | 2 |
SLC1A5 | Solute carrier family 1 (neutral amino acid transporter), member 5 | U53347, AF105230, AF105423 | U53347 | |
SLC20A1 | Solute carrier family 20 (phosphate transporter), member 1 | AF102059, AF102060, AF102061, AF102062, AF102063 | ||
SLC20A2 | Solute carrier family 20 (phosphate transporter), member 2 | |||
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | |||
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | J03810 | J03810 | 1 |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | M20747 | M91463 | |
SLC3A1 | Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1 | D82326 | D82326 | 1 |
SLC4A1 | Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | M27819, X12609 | M27819 | |
SLC5A5 | Solute carrier family 5 (sodium iodide symporter), member 5 | U66088 | ||
SLC6A2 | Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | M65105 | X91117 | 1 |
SLC6A3 | Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | L24178, M95167 | ||
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | L05568, X70697 | ||
SLC7A7 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 | AF092032 | AJ130718 | |
SLC9A1 | Solute carrier family 9 (sodium/hydrogen exchanger), isoform 1 (antiporter, Na+/H+, amiloride sensitive) | M81768, S68616 | S68616 | |
SLEB1 | Systemic lupus erythematosus susceptibility 1 | |||
SLPI | Secretory leukocyte protease inhibitor (antileukoproteinase) | X04502 | X04470 | 1 |
SM1 | Schistosoma mansoni, susceptibility/resistance to | |||
SMN1 | Survival of motor neuron 1, telomeric | U18423, AH006635 | ||
SNAP23 | Synaptosomal-associated protein, 23kD | U55936, Y09567, Y09568 | AJ011915 | 1 |
SNCG | Synuclein, gamma (breast cancer-specific protein 1) | AF044311 | AF044311 | 2 |
SNRP70 | Small nuclear ribonucleoprotein 70kD polypeptide (RNP antigen) | X04654 | X04654 | |
SNRPB | Small nuclear ribonucleoprotein polypeptides B and B1 | J04564, M34081, X17567, X17568 | J04564 | |
SNRPN | Small nuclear ribonucleoprotein polypeptide N | U41303, X15892 | ||
SOAT1 | Sterol O-acyltransferase (acyl-Coenzyme A: cholesterol acyltransferase) 1 | L21934, AF059202 | AF059202 L21934 | |
SOD1 | Superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | K00065, X02317 | X02317 | 2 |
SOD2 | Superoxide dismutase 2, mitochondrial | M36693, X07834, X14322, X15132, X59445, Y00985 | X07834 | Location 1 (1) Location 2 (5) |
SORL1 | Sortilin-related receptor, L(DLR class) A repeats-containing | Y08110 | ||
SOX10 | SRY (sex-determining region Y)-box 10 | |||
SOX4 | SRY (sex determining region Y)-box 4 | X70683 | X70683 | 2 |
SPG3A | Spastic paraplegia 3A (autosomal dominant) | |||
SPN | Sialophorin (gpL115, leukosialin, CD43) | J04168, J04536, X52075 | X52075 | |
SPN | Sialophorin (gpL115, leukosialin, CD43) | J04168, J04536, X52075 | X52075 | |
SPP1 | Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) | J04765, M83248, X13694 | AF052124 | Location 1 (2) Location 2 (2) |
SPTA1 | Spectrin, alpha, erythrocytic 1 (elliptocytosis 2) | M61877 | M61877 | 1 |
SRD5A2 | Steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) | M74047 | ||
SSA2 | Sjogren syndrome antigen A2 (60kD, ribonucleoprotein autoantigen SS-A/Ro) | J04137 | M25077 | 1 |
SSB | Sjogren syndrome antigen B (autoantigen La) | J04205, M20328, X13697, X14684 | X69804 | Location 1 (2) Location 2 (1) |
SSTR1 | Somatostatin receptor 1 | M81829 | ||
ST3 | Suppression of tumorigenicity 3 | |||
STAM | Signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 | U43899 | U43899 | 1 |
STAT1 | Signal transducer and activator of transcription 1, 91kD | U18662, U18663, U18664, U18665, U18666, U18667, U18668, U18669, U18670 | ||
STAT2 | Signal transducer and activator of transcription 2, 113kD | U18671 | U18671 | |
STAT3 | Signal transducer and activator of transcription 3 (acute-phase response factor) | L29277 | L29277 | |
STAT4 | Signal transducer and activator of transcription 4 | L78440 | L78440 | |
STAT5A | Signal transducer and activator of transcription 5A | L41142, U43185, U47686 | U43185 U47686 | |
STAT6 | Signal transducer and activator of transcription 6, interleukin-4 induced | AF067572, AF067573 | ||
STATH | Statherin | M18078, M18371 | ||
STATI2 | STAT induced STAT inhibitor-2 | AB004903, AB006966, AF037989 | AF037989 | 1 |
STX1B | Syntaxin 1B | D37933 | ||
SULT1A1 | Sulfotransferase family 1A, phenol-preferring, member 1 | U52852, U71086 | U52852 | 1 |
SULT1A3 | Sulfotransferase family 1A, phenol-preferring, member 3 | U20499 | L19956 | |
SULT2A1 | Sulfotransferase family 2A, dehydroepiandrosterone (DHEA) -preferring, member 1 | X70222 | U13061 | |
SUOX | Sulfite oxidase | L31573 | L31573 | |
SUR | Sulfonylurea receptor (hyperinsulinemia) | L40625, L78207, U63421 | L78207 | |
SURF1 | Surfeit 1 | Z35093 | Z35093 | |
SW | Swann blood group | |||
T | T brachyury (mouse) homolog | AJ001699 | ||
TAP1 | Transporter 1, ABC (ATP binding cassette) | L21204 | X57522 Z14982 X62744 U15085 Z14977 X03066 M16276 | Location 1 (3) Location 2 (1) Location 3 (1) Location 4 (1) Location 5 (2) |
TAP2 | Transporter 2, ABC (ATP binding cassette) | M74447, X87344, Z22935, Z22936 | X57522 Z14982 X62744 U15085 Z14977 X03066 M16276 | Location 1 (3) Location 2 (1) Location 3 (1) Location 4 (1) Location 5 (2) |
TAT | Tyrosine aminotransferase | X52520, X55675 | X52520 | |
TAZ | Tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) | X92762 | X92762 | |
TBG | Thyroxin-binding globulin | M14091 | Z83850 | |
TBP | TATA box binding protein | M55654 | M55654 AL031259 | 3 |
TBX2 | T-box 2 | U28049 | U28049 | |
TBXA2R | Thromboxane A2 receptor | D38081, U11271, U27325 | AC005175 D38081 | |
TBXAS1 | Thromboxane A synthase 1 (platelet, cytochrome P450, subfamily V) | M80647 | L36087 | |
TCF1 | Transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor | M57732, U72618 | M57732 | |
TCF19 | Transcription factor 19 (SC1) | |||
TCF3 | Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | M31222 | M31523 | 2 |
TCF7 | Transcription factor 7 (T-cell specific, HMG-box) | X59869 | ||
TCF8 | Transcription factor 8 (represses interleukin 2 expression) | |||
TCL1A | T-cell leukemia/lymphoma 1A | X82240, X82241 | X82240 | |
TCL4 | T-cell leukemia/lymphoma 4 | |||
TCN1 | Transcobalamin I (vitamin B12 binding protein, R binder family) | J05068 | J05068 | |
TCN2 | Transcobalamin II; macrocytic anemia | L02647, L02648, M60396 | L02648 | 1 |
TCP1 | T-complex 1 | |||
TCRA | T-cell receptor, alpha (V,D,J,C) | M12959, X01403, X02592, X64643 | X64643 M12959 | Location 1 (3) Location 2 (1) |
TCRB | T-cell receptor, beta cluster | K02779, K02780, K02885, M12886, M15564, U66059, U66060, U66061, X00427, X01410, X01411, X01417, X02515, X63456 | U66061 | 1 |
TCRB | T-cell receptor, beta cluster | K02779, K02780, K02885, M12886, M15564, U66059, U66060, U66061, X00427, X01410, X01411, X01417, X02515, X63456 | U66061 | 1 |
TCRG | T-cell receptor, gamma cluster | M27331, M27332, M27334, M30894, Y00790 | M30894 | |
TCTE1 | T-complex-associated-testis-expressed 1 | |||
TDO2 | Tryptophan 2,3-dioxygenase | U32989 | U32989 | |
TECTA | Tectorin alpha | AF055136, AH006302 | ||
TERF2 | Telomeric repeat binding factor 2 | AF002999 | AF002999 | |
TF | Transferrin | M12530, S95936 | S95936 | Location 1 (1) Location 2 (5) |
TFF2 | Trefoil factor 2 (spasmolytic protein 1) | U47292, X51698 | ||
TFPI | Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | J03225, M58650, M59499 | M59499 | |
TFPI2 | Tissue factor pathway inhibitor-2 | |||
TFRC | Transferrin receptor (p90, CD71) | M11507, X01060 | X01060 | 2 |
TG | Thyroglobulin | U93033 | U93033 | 1 |
TGFB1 | Transforming growth factor, beta 1 | X02812 | X02812 | |
TGFB2 | Transforming growth factor, beta 2 | M19154, Y00083 | Y00083 M19154 | |
TGFB3 | Transforming growth factor, beta 3 | J03241, X14149, X14885 | AF107885 X14885 | 1 |
TGFBI | Transforming growth factor, beta-induced, 68kD | M77349 | M77349 | 4 |
TGFBR3 | Transforming growth factor, beta receptor III (betaglycan, 300kD) | L07594 | L07594 | |
TGM1 | Transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) | D90287, M55183, M62925, X57974 | ||
TGM2 | Transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | M55153 | M55153 | 1 |
TH | Tyrosine hydroxylase | M17589, X05290, Y00414 | ||
THBS1 | Thrombospondin 1 | M99425, X04665 | X14787 | 1 |
THBS2 | Thrombospondin 2 | L12350 | L12350 | Location 1 (4) Location 2 (4) |
THPO | Thrombopoietin (myeloproliferative leukemia virus oncogene ligand, megakaryocyte growth and development factor) | L33410 | ||
THRA | Thyroid hormone receptor, alpha (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog) | M24748 | M24898 | |
THRB | Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog 2) | M26747, X04707 | ||
THY1 | Thy-1 cell surface antigen | M11749 | M11749 | 1 |
TIEG | TGFB inducible early growth response | S81439, U21847 | S81439 | 1 |
TIMP3 | Tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) | S78453, U02571, U14394, U67195, X76227 | AL023282 | 3 |
TK1 | Thymidine kinase 1, soluble | K02581, M15205 | K02581 | |
TKT | Transketolase (Wernicke-Korsakoff syndrome) | |||
TLR1 | Toll-like receptor 1 | U88540 | D13637 | |
TLR2 | Toll-like receptor 2 | U88878 | AF051152 | |
TLR3 | Toll-like receptor 3 | U88879 | ||
TLR4 | Toll-like receptor 4 | U88880, U93091 | U93091 | |
TLR5 | Toll-like receptor 5 | U08888 | ||
TM4SF7 | Transmembrane 4 superfamily member 7 | AF022813 | AF022813 | 2 |
TMEM1 | Transmembrane protein 1 | U19252, U61500, U61520 | AB001523 AB001517 | 1 |
TNF | Tumor necrosis factor (TNF superfamily, member 2) | M10988, M16441, X01394 | X02910 D12614 Y14768 | |
TNFAIP2 | Tumor necrosis factor, alpha-induced protein 2 | M92357 | M92357 | 1 |
TNFAIP6 | Tumor necrosis factor, alpha-induced protein 6 | |||
TNFRSF11B | Tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) | U94332 | AB008822 | |
TNFRSF12 | Tumor necrosis factor receptor superfamily, member 12 (translocating chain-association membrane protein) | U72763 | AB018263 | 1 |
TNFRSF14 | Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | U70321 | U70321 | 1 |
TNFRSF17 | Tumor necrosis factor receptor superfamily, member 17 | Z29574 | Z29574 | |
TNFRSF1A | Tumor necrosis factor receptor superfamily, member 1A | M33294, M75866 | ||
TNFRSF1B | Tumor necrosis factor receptor superfamily, member 1B | M32315, M35857, M55994 | M32315 | |
TNFRSF5 | Tumor necrosis factor receptor superfamily, member 5 | X60592 | X60592 | |
TNFRSF6 | Tumor necrosis factor receptor superfamily, member 6 | M67454, X63717 | X63717 | |
TNFRSF6B | Tumor necrosis factor receptor superfamily, member 6b, decoy | AF104419 | ||
TNFRSF7 | Tumor necrosis factor receptor superfamily, member 7 | M63928 | M63928 | |
TNFRSF9 | Tumor necrosis factor receptor superfamily, member 9 | L12964 | ||
TNFSF11 | Tumor necrosis factor (ligand) superfamily, member 11 | AF013171, AF019047, AF053712 | ||
TNFSF12 | Tumor necrosis factor (ligand) superfamily, member 12 | AF030099 | AF055872 | |
TNFSF14 | Tumor necrosis factor (ligand) superfamily, member 14 | AF036581 | ||
TNFSF5 | Tumor necrosis factor (ligand) superfamily, member 5 | D31793, L07414 | ||
TNFSF6 | Tumor necrosis factor (ligand) superfamily, member 6 | U11821, X89102 | ||
TNNT2 | Troponin T2, cardiac | L40162, S64668, X74819, X79857, AF004415 | X74819 | |
TP53 | Tumor protein p53 (Li-Fraumeni syndrome) | K03199, M13121, X02469, X54156 | X54156 | |
TP73 | Tumor protein p73 | Y11416 | ||
TPH | Tryptophan hydroxylase (tryptophan 5-monooxygenase) | X52836 | AF057280 | |
TPI1 | Triosephosphate isomerase 1 | M10036 | U47924 | 2 |
TPM1 | Tropomyosin 1 (alpha) | M19713, X12369 | M19267 | Location 1 (2) Location 2 (1) Location 3 (1) |
TPMT | Thiopurine S-methyltransferase | S62904 | ||
TPO | Thyroid peroxidase | J02969, J02970, M25715, M55702, X17358, Y00406 | ||
TPT1 | Tumor protein, translationally-controlled 1 | X16064 | ||
TRAF1 | TNF receptor-associated factor 1 | U19261 | U19261 | |
TRAF1 | TNF receptor-associated factor 1 | U19261 | U19261 | |
TRAF2 | TNF receptor-associated factor 2 | U12597 | U12597 | |
TRAF3 | TNF receptor-associated factor 3 | U15637, U21092 | U21092 | |
TRAF4 | TNF receptor-associated factor 4 | X80200 | X80200 | 1 |
TRAF5 | TNF receptor-associated factor 5 | U69108, AB000509 | AB000509 | |
TRAF6 | TNF receptor-associated factor 6 | U78798 | U78798 | |
TRP1 | TRNA proline 1 | |||
TSHB | Thyroid stimulating hormone, beta | M23671 | ||
TSHR | Thyroid stimulating hormone receptor | M31774, M32215, M73747 | ||
TSSC3 | Tumor suppressing subtransferable candidate 3 | AF035444 | AF035444 | Location 1 (1) Location 2 (1) |
TST | Thiosulfate sulfurtransferase (rhodanese) | D87292, X59434 | X59434 D87292 | 1 |
TSTA3 | Tissue specific transplantation antigen P35B | U58766 | U58766 | 1 |
TTIM1 | T-cell tumor invasion and metastasis 1 | |||
TTR | Transthyretin (prealbumin, amyloidosis type I) | D00096, K02091, M10605, M11714 | D00096 | 1 |
TUB | Tubby (mouse) homolog | U54644 | ||
TUBA3 | Tubulin, alpha, brain-specific | X01703 | ||
TUBAL1 | Tubulin, alpha-like 1 | |||
TUBB | Tubulin, beta polypeptide | X79535 | X79535 | |
TWIST | Twist (Drosophila) homolog | U80998, Y10871 | ||
TXN | Thioredoxin | J04026, X77584 | X77584 | 1 |
U2AF1 | U2(RNU2) small nuclear RNA auxillary factor 1 (non-standard symbol) | |||
UBC | Ubiquitin C | AB009010 | M26880 | Location 1 (1) Location 2 (1) Location 3 (2) Location 4 (3) Location 5 (13) |
UBE1 | Ubiquitin-activating enzyme E1 (A1S9T and BN75 temperature sensitivity complementing) | |||
UBE2B | Ubiquitin-conjugating enzyme E2B (RAD6 homolog) | M74525, X53251 | M74525 | |
UBE2I | Ubiquitin-conjugating enzyme E2I (homologous to yeast UBC9) | D45050 | U66867 | 5 |
UBE2V2 | Ubiquitin-conjugating enzyme E2 variant 2 | |||
UBE3A | Ubiquitin protein ligase E3A (human papilloma virus E6-associated protein, Angelman syndrome) | X98031 | U84404 | |
UBL1 | Ubiquitin-like 1 (sentrin) | U83117 | U83117 | |
UCP2 | Uncoupling protein 2 (mitochondrial, proton carrier) | U76367, U82819 | ||
UCP3 | Uncoupling protein 3 (mitochondrial, proton carrier) | |||
UFS | Urofacial syndrome | |||
UGB | Uteroglobin | |||
UGDH | UDP-glucose dehydrogenase | |||
UGT1 | UDP glycosyltransferase 1 | M57899, M84127, M84128, AF030310 | J04093 | 1 |
UMPK | Uridine monophosphate kinase | |||
UMPS | Uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase) | J03626 | J03626 | 1 |
UP | Uridine phosphorylase | X90858 | X90858 | |
UPK1B | Uroplakin 1B | |||
UROD | Uroporphyrinogen decarboxylase | M14016 | X89267 | 1 |
UROS | Uroporphyrinogen III synthase (congenital erythropoietic porphyria) | J03824 | J03824 | |
USH2A | Usher syndrome 2A (autosomal recessive, mild) | |||
USP7 | Ubiquitin specific protease 7 (herpes virus-associated) | |||
VASP | Vasodilator-stimulated phosphoprotein | Z46389 | Z46389 | 2 |
VCAM1 | Vascular cell adhesion molecule 1 | M30257, M60335 | M30257 | |
VDAC1 | Voltage-dependent anion channel 1 | L06132 | L06132 | 2 |
VDR | Vitamin D (1,25- dihydroxyvitamin D3) receptor | J03258 | J03258 | 2 |
VHL | Von Hippel-Lindau syndrome | L15409, AF010238 | AF010238 | |
VMD2 | Vitelliform macular dystrophy (Best disease, bestrophin) | AF073501 | AF057169 | |
VPREB1 | Pre-B lymphocyte gene 1 (non-standard provisional symbol) | |||
VPREB2 | Pre-B lymphocyte-specific protein-2 | |||
VSD1 | Ventricular septal defect 1 | |||
VTN | Vitronectin (serum spreading factor, somatomedin B, complement S-protein) | X03168 | X03168 | 1 |
VWF | Von Willebrand factor | K03028, M25865 | ||
WAS | Wiskott-Aldrich syndrome (ecezema-thrombocytopenia) | U12707, U19927 | U12707 | |
WEE1 | Wee1+ (S. pombe) homolog | U10564 | ||
WFS | Wolfram syndrome | Y18064 | AF084481 | 2 |
WT1 | Wilms tumor 1 | X51630 | X51630 | |
WT3 | Wilms tumor-3 | |||
WWS | Wieacker-Wolff syndrome | |||
XBP1 | X-box binding protein 1 | M31627 | M31627 | 1 |
XG | Xg blood group (pseudoautosomal boundary-divided on the X chromosome) | |||
XGR | Expression of XG and MIC2 on erythrocytes | |||
XK | Kell blood group precursor (McLeod phenotype) | Z32684 | ||
XPA | Xeroderma pigmentosum, complementation group A | D14533 | D14533 | |
XPC | Xeroderma pigmentosum, complementation group C | D21089, X65024 | D21089 | |
XPNPEPL | X-prolyl aminopeptidase (aminopeptidase P)-like | |||
XRCC1 | X-ray repair complementing defective repair in Chinese hamster cells 1 | M36089 | M36089 | |
XRCC2 | X-ray repair complementing defective repair in Chinese hamster cells 2 | AF035587 | AF035587 | |
XRCC3 | X-ray repair complementing defective repair in Chinese hamster cells 3 | AF035586 | ||
YB1 | Major histocompatibility complex, class II, Y box-binding protein I; DNA-binding protein B | J03827, M24070 | J03827 | 1 |
ZFP161 | Zinc finger protein homologous to Zfp161 in mouse | D89859, Y12726 | D89859 | 3 |
ZFP36 | Zinc finger protein homologous to Zfp-36 in mouse | M92843 | M92843 | 1 |
ZFY | Zinc finger protein, Y-linked | M30607 | ||
ZNF121 | Zinc finger protein 121 (clone ZHC32) | M99593 | ||
ZRK | Zona pellucida receptor tyrosine kinase, 95kD | L08961 |